Form990
Department of the Treasury
Internal Revenue Service
Return of Organization Exempt From Income Tax
Under section 501(c), 527, or 4947(a)(1) of the Internal Revenue Code (except private foundations)
MediumBullet Do not enter Social Security numbers on this form as it may be made public. By law, the IRS
generally cannot redact the information on the form.
MediumBullet Information about Form 990 and its instructions is at www.IRS.gov/form990.
OMB No. 1545-0047
2013
Open to Public Inspection
A For the 2013 calendar year, or tax year beginning 01-01-2013 , 2013, and ending 12-31-2013
BCheck if applicable:
CName of organization
American Diabetes Association Research Foundation Inc
 
Doing Business As
 
 
Number and street (or P.O. box if mail is not delivered to street address)
1701 N Beauregard Street
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
Alexandria, VA22311
D Employer identification number

54-1734511
E Telephone number

G Gross receipts $ 40,350,068
F Name and address of principal officer:
Larry Hausner CEO
1701 N Beauregard Street
Alexandria,VA22311
I
Tax-exempt status: (   ) LeftBullet (insert no.) or
J
Website:MediumBullet
www.diabetes.org/news-research
H(a)
Is this a group return for
subordinates?
H(b)
Are all subordinates
included?
If "No," attach a list. (see instructions) Click to see attachment
H(c)
Group exemption number MediumBullet3326
K Form of organization:
 
L Year of formation: 1994
M State of legal domicile: VA
Part I
Summary
Activities & Governance 1 Briefly describe the organization’s mission or most significant activities: The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research Please see complete mission statement in schedule O.
2 Check this box MediumBullet
3 Number of voting members of the governing body (Part VI, line 1a) ........ 3 13
4 Number of independent voting members of the governing body (Part VI, line 1b) ..... 4 13
5 Total number of individuals employed in calendar year 2013 (Part V, line 2a) ...... 5 0
6 Total number of volunteers (estimate if necessary) ............. 6 180
7a Total unrelated business revenue from Part VIII, column (C), line 12 ........ 7a 0
b Net unrelated business taxable income from Form 990-T, line 34 ......... 7b  
Revenues Prior Year Current Year
8 Contributions and grants (Part VIII, line 1h) ......... 55,590,601 40,345,846
9 Program service revenue (Part VIII, line 2g) .........   0
10 Investment income (Part VIII, column (A), lines 3, 4, and 7d ) .... 3,388 4,222
11 Other revenue (Part VIII, column (A), lines 5, 6d, 8c, 9c, 10c, and 11e)   0
12 Total revenue—add lines 8 through 11 (must equal Part VIII, column (A), line 12)................... 55,593,989 40,350,068
Expenses; 13 Grants and similar amounts paid (Part IX, column (A), lines 1–3 )... 35,546,004 36,131,583
14 Benefits paid to or for members (Part IX, column (A), line 4).....   0
15 Salaries, other compensation, employee benefits (Part IX, column (A), lines 5–10)   0
16a Professional fundraising fees (Part IX, column (A), line 11e).....   0
b Total fundraising expenses (Part IX, column (D), line 25) MediumBullet818,122    
17 Other expenses (Part IX, column (A), lines 11a–11d, 11f–24e).... 1,216,401 1,308,995
18 Total expenses. Add lines 13–17 (must equal Part IX, column (A), line 25) 36,762,405 37,440,578
19 Revenue less expenses. Subtract line 18 from line 12....... 18,831,584 2,909,490
Net Assets or Fund Balances; Beginning of Current Year End of Year
20 Total assets (Part X, line 16)............. 35,154,688 41,259,338
21 Total liabilities (Part X, line 26)............. 10,265,209 12,833,035
22 Net assets or fund balances. Subtract line 21 from line 20..... 24,889,479 28,426,303
Part II
Signature Block
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than officer) is based on all information of which preparer has any knowledge.
Sign Here
JumboBullet
Signature of officer Date
JumboBullet
Type or print name and title
Paid Preparer Use Only
Print/Type preparer's name
Preparer's signature
Date
PTIN
Firm's name MediumBullet

Firm's EIN MediumBullet
Firm's address MediumBullet



Phone no.
May the IRS discuss this return with the preparer shown above? (see instructions) ............
For Paperwork Reduction Act Notice, see the separate instructions.
Cat. No. 11282Y
Form 990 (2013)
Form 990 (2013)
Page 2
Part III
Statement of Program Service Accomplishments
Check if Schedule O contains a response or note to any line in this Part III ..............
1
Briefly describe the organization’s mission: The Foundation was founded to give focus to the American Diabetes Associations research program and to ensure the availability of funds to support research.
2
Did the organization undertake any significant program services during the year which were not listed on
the prior Form 990 or 990-EZ? ......................
If "Yes," describe these new services on Schedule O.
3
Did the organization cease conducting, or make significant changes in how it conducts, any program services? ............................
If "Yes," describe these changes on Schedule O.
4
Describe the organization’s program service accomplishments for each of its three largest program services, as measured by expenses. Section 501(c)(3) and 501(c)(4) organizations are required to report the amount of grants and allocations to others, the total expenses, and revenue, if any, for each program service reported.
4a (Code:   ) (Expenses $ 36,131,583 including grants of $ 36,131,583 ) (Revenue $   )
Research See Schedule O
4b (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4c (Code:   ) (Expenses $   including grants of $   ) (Revenue $   )
4d Other program services (Describe in Schedule O.)
(Expenses $   including grants of $   ) (Revenue $   )
4e Total program service expensesMediumBullet36,131,583
Form 990 (2013)
Form 990 (2013)
Page 3
Part IV
Checklist of Required Schedules
Yes
No
1
Is the organization described in section 501(c)(3) or 4947(a)(1) (other than a private foundation)? If "Yes," complete Schedule AClick to see attachment........................
1
Yes
 
2
Is the organization required to complete Schedule B, Schedule of Contributors (see instructions)? Click to see attachment...
2
Yes
 
3
Did the organization engage in direct or indirect political campaign activities on behalf of or in opposition to candidates for public office? If "Yes," complete Schedule C, Part I..........
3
 
No
4
Section 501(c)(3) organizations. Did the organization engage in lobbying activities, or have a section 501(h) election in effect during the tax year? If "Yes," complete Schedule C, Part II........
4
 
No
5
Is the organization a section 501(c)(4), 501(c)(5), or 501(c)(6) organization that receives membership dues, assessments, or similar amounts as defined in Revenue Procedure 98-19? If "Yes," complete Schedule C,
Part III............................
5
 
 
6
Did the organization maintain any donor advised funds or any similar funds or accounts for which donors have the right to provide advice on the distribution or investment of amounts in such funds or accounts? If "Yes," complete Schedule D, Part I........................
6
 
No
7
Did the organization receive or hold a conservation easement, including easements to preserve open space,
the environment, historic land areas, or historic structures? If "Yes," complete Schedule D, Part II...
7
 
No
8
Did the organization maintain collections of works of art, historical treasures, or other similar assets? If "Yes," complete Schedule D, Part III ....................
8
 
No
9
Did the organization report an amount in Part X, line 21 for escrow or custodial account liability; serve as a custodian for amounts not listed in Part X; or provide credit counseling, debt management, credit repair, or debt negotiation services? If "Yes," complete Schedule D, Part IV..............
9
 
No
10
Did the organization, directly or through a related organization, hold assets in temporarily restricted endowments, permanent endowments, or quasi-endowments? If "Yes," complete Schedule D, Part V......
10
 
No
11
If the organization’s answer to any of the following questions is "Yes," then complete Schedule D, Parts VI, VII, VIII, IX, or X as applicable.
a
Did the organization report an amount for land, buildings, and equipment in Part X, line 10?
If "Yes," complete Schedule D, Part VI....................
11a
 
No
b
Did the organization report an amount for investments—other securities in Part X, line 12 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VII.......
11b
 
No
c
Did the organization report an amount for investments—program related in Part X, line 13 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part VIII.......
11c
 
No
d
Did the organization report an amount for other assets in Part X, line 15 that is 5% or more of its total assets reported in Part X, line 16? If "Yes," complete Schedule D, Part IX............
11d
 
No
e
Did the organization report an amount for other liabilities in Part X, line 25? If "Yes," complete Schedule D, Part X
11e
 
No
f
Did the organization’s separate or consolidated financial statements for the tax year include a footnote that addresses the organization’s liability for uncertain tax positions under FIN 48 (ASC 740)? If "Yes," complete Schedule D, Part XClick to see attachment.........................
11f
Yes
 
12a
Did the organization obtain separate, independent audited financial statements for the tax year?
If "Yes," complete Schedule D, Parts XI and XII Click to see attachment.................
12a
Yes
 
b
Was the organization included in consolidated, independent audited financial statements for the tax year? If "Yes," and if the organization answered "No" to line 12a, then completing Schedule D, Parts XI and XII is optional Click to see attachment
12b
Yes
 
13
Is the organization a school described in section 170(b)(1)(A)(ii)? If "Yes," complete Schedule E....
13
 
No
14a
Did the organization maintain an office, employees, or agents outside of the United States?.....
14a
 
No
b
Did the organization have aggregate revenues or expenses of more than $10,000 from grantmaking, fundraising, business, investment, and program service activities outside the United States, or aggregate foreign investments valued at $100,000 or more? If "Yes," complete Schedule F, Parts I and IV......... Click to see attachment
14b
Yes
 
15
Did the organization report on Part IX, column (A), line 3, more than $5,000 of grants or other assistance to or for any foreign organization? If “Yes,” complete Schedule F, Parts II and IVClick to see attachment
15
Yes
 
16
Did the organization report on Part IX, column (A), line 3, more than $5,000 of aggregate grants or other assistance to or for foreign individuals? If “Yes,” complete Schedule F, Parts III and IV...
16
 
No
17
Did the organization report a total of more than $15,000 of expenses for professional fundraising services on Part IX, column (A), lines 6 and 11e? If "Yes," complete Schedule G, Part I (see instructions)....
17
 
No
18
Did the organization report more than $15,000 total of fundraising event gross income and contributions on Part VIII, lines 1c and 8a? If "Yes," complete Schedule G, Part II............
18
 
No
19
Did the organization report more than $15,000 of gross income from gaming activities on Part VIII, line 9a? If "Yes," complete Schedule G, Part III...................
19
 
No
20a
Did the organization operate one or more hospital facilities? If "Yes," complete Schedule H....
20a
 
No
b
If "Yes" to line 20a, did the organization attach a copy of its audited financial statements to this return?
20b
 
 
Form 990 (2013)
Form 990 (2013)
Page 4
Part IV
Checklist of Required Schedules (continued)
21
Did the organization report more than $5,000 of grants or other assistance to any domestic organization or government on Part IX, column (A), line 1? If “Yes,” complete Schedule I, Parts I and II... Click to see attachment
21
Yes
 
22
Did the organization report more than $5,000 of grants or other assistance to individuals in the United States on Part IX, column (A), line 2? If “Yes,” complete Schedule I, Parts I and III........ Click to see attachment
22
Yes
 
23
Did the organization answer "Yes" to Part VII, Section A, line 3, 4, or 5 about compensation of the organization’s current and former officers, directors, trustees, key employees, and highest compensated employees? If "Yes," complete Schedule J....................... Click to see attachment
23
Yes
 
24a
Did the organization have a tax-exempt bond issue with an outstanding principal amount of more than $100,000 as of the last day of the year, that was issued after December 31, 2002? If “Yes,” answer lines 24b through 24d and complete Schedule K. If “No,” go to line 25a................
24a
 
No
b
Did the organization invest any proceeds of tax-exempt bonds beyond a temporary period exception?...
24b
 
No
c
Did the organization maintain an escrow account other than a refunding escrow at any time during the year
to defease any tax-exempt bonds?......................
24c
 
No
d
Did the organization act as an "on behalf of" issuer for bonds outstanding at any time during the year?...
24d
 
No
25a
Section 501(c)(3) and 501(c)(4) organizations. Did the organization engage in an excess benefit transaction with a disqualified person during the year? If "Yes," complete Schedule L, Part I........
25a
 
No
b
Is the organization aware that it engaged in an excess benefit transaction with a disqualified person in a prior year, and that the transaction has not been reported on any of the organization’s prior Forms 990 or 990-EZ? If "Yes," complete Schedule L, Part I...................
25b
 
No
26
Did the organization report any amount on Part X, line 5, 6, or 22 for receivables from or payables to any current or former officers, directors, trustees, key employees, highest compensated employees, or disqualified persons? If so, complete Schedule L, Part II....................
26
 
No
27
Did the organization provide a grant or other assistance to an officer, director, trustee, key employee, substantial contributor or employee thereof, a grant selection committee member, or to a 35% controlled entity or family member of any of these persons? If "Yes," complete Schedule L, Part III......... Click to see attachment
27
Yes
 
28
Was the organization a party to a business transaction with one of the following parties (see Schedule L, Part IV instructions for applicable filing thresholds, conditions, and exceptions):
a
A current or former officer, director, trustee, or key employee? If "Yes," complete Schedule L, Part IV ..........................
28a
 
No
b
A family member of a current or former officer, director, trustee, or key employee? If "Yes,"
complete Schedule L, Part IV.....................
28b
 
No
c
An entity of which a current or former officer, director, trustee, or key employee (or a family member thereof) was an officer, director, trustee, or direct or indirect owner? If "Yes," complete Schedule L, Part IV...
28c
 
No
29
Did the organization receive more than $25,000 in non-cash contributions? If "Yes," complete Schedule M..
29
 
No
30
Did the organization receive contributions of art, historical treasures, or other similar assets, or qualified conservation contributions? If "Yes," complete Schedule M.............
30
 
No
31
Did the organization liquidate, terminate, or dissolve and cease operations? If "Yes," complete Schedule N,
Part I...........................
31
 
No
32
Did the organization sell, exchange, dispose of, or transfer more than 25% of its net assets? If "Yes," complete Schedule N, Part II......................
32
 
No
33
Did the organization own 100% of an entity disregarded as separate from the organization under Regulations sections 301.7701-2 and 301.7701-3? If "Yes," complete Schedule R, Part I........
33
 
No
34
Was the organization related to any tax-exempt or taxable entity? If "Yes," complete Schedule R, Part II, III, or IV, and Part V, line 1........................ Click to see attachment
34
Yes
 
35a
Did the organization have a controlled entity within the meaning of section 512(b)(13)?
35a
 
No
b
If ‘Yes’ to line 35a, did the organization receive any payment from or engage in any transaction with a controlled entity within the meaning of section 512(b)(13)? If "Yes," complete Schedule R, Part V, line 2...
35b
 
 
36
Section 501(c)(3) organizations. Did the organization make any transfers to an exempt non-charitable related organization? If "Yes," complete Schedule R, Part V, line 2.............
36
 
No
37
Did the organization conduct more than 5% of its activities through an entity that is not a related organization and that is treated as a partnership for federal income tax purposes? If "Yes," complete Schedule R, Part VI
37
 
No
38
Did the organization complete Schedule O and provide explanations in Schedule O for Part VI, lines 11b and 19? Note. All Form 990 filers are required to complete Schedule O. ............
38
Yes
 
Form 990 (2013)
Form 990 (2013)
Page 5
Part V
Statements Regarding Other IRS Filings and Tax Compliance
Check if Schedule O contains a response or note to any line in this Part V ..............
Yes
No
1a
Enter the number reported in Box 3 of Form 1096 Enter -0- if not applicable ..
1a
0
b
Enter the number of Forms W-2G included in line 1a. Enter -0- if not applicable .
1b
0
c
Did the organization comply with backup withholding rules for reportable payments to vendors and reportable gaming (gambling) winnings to prize winners? ..................
1c
 
 
2a
Enter the number of employees reported on Form W-3, Transmittal of Wage and
Tax Statements, filed for the calendar year ending with or within the year covered by this return ..................
2a
0
b
If at least one is reported on line 2a, did the organization file all required federal employment tax returns?
Note. If the sum of lines 1a and 2a is greater than 250, you may be required to e-file (see instructions)
2b
 
 
3a
Did the organization have unrelated business gross income of $1,000 or more during the year?...
3a
 
No
b
If “Yes,” has it filed a Form 990-T for this year? If “No” to line 3b, provide an explanation in Schedule O...
3b
 
 
4a
At any time during the calendar year, did the organization have an interest in, or a signature or other authority over, a financial account in a foreign country (such as a bank account, securities account, or other financial account)?..........................
4a
 
No
b
If "Yes," enter the name of the foreign country: MediumBullet
See instructions for filing requirements for Form TD F 90-22.1, Report of Foreign Bank and Financial Accounts.
5a
Was the organization a party to a prohibited tax shelter transaction at any time during the tax year?..
5a
 
No
b
Did any taxable party notify the organization that it was or is a party to a prohibited tax shelter transaction?
5b
 
No
c
If "Yes," to line 5a or 5b, did the organization file Form 8886-T? ............
5c
 
 
6a
Does the organization have annual gross receipts that are normally greater than $100,000, and did the organization solicit any contributions that were not tax deductible as charitable contributions?...
6a
 
No
b
If "Yes," did the organization include with every solicitation an express statement that such contributions or gifts were not tax deductible?........................
6b
 
 
7
Organizations that may receive deductible contributions under section 170(c).
a
Did the organization receive a payment in excess of $75 made partly as a contribution and partly for goods and services provided to the payor?....................
7a
 
No
b
If "Yes," did the organization notify the donor of the value of the goods or services provided?.....
7b
 
 
c
Did the organization sell, exchange, or otherwise dispose of tangible personal property for which it was required to file Form 8282?...........................
7c
 
No
d
If "Yes," indicate the number of Forms 8282 filed during the year ....
7d
 
e
Did the organization receive any funds, directly or indirectly, to pay premiums on a personal benefit contract?............................
7e
 
No
f
Did the organization, during the year, pay premiums, directly or indirectly, on a personal benefit contract?..
7f
 
No
g
If the organization received a contribution of qualified intellectual property, did the organization file Form 8899 as required?............................
7g
 
 
h
If the organization received a contribution of cars, boats, airplanes, or other vehicles, did the organization file a Form 1098-C?..........................
7h
 
 
8
Sponsoring organizations maintaining donor advised funds and section 509(a)(3) supporting organizations. Did the supporting organization, or a donor advised fund maintained by a sponsoring organization, have excess business holdings at any time during the year?............
8
 
 
9
Sponsoring organizations maintaining donor advised funds.
a
Did the organization make any taxable distributions under section 4966?..........
9a
 
 
b
Did the organization make a distribution to a donor, donor advisor, or related person?.......
9b
 
 
10
Section 501(c)(7) organizations. Enter:
a
Initiation fees and capital contributions included on Part VIII, line 12 ...
10a
 
b
Gross receipts, included on Form 990, Part VIII, line 12, for public use of club facilities
10b
 
11
Section 501(c)(12) organizations. Enter:
a
Gross income from members or shareholders .........
11a
 
b
Gross income from other sources (Do not net amounts due or paid to other sources against amounts due or received from them.) ..........
11b
 
12a
Section 4947(a)(1) non-exempt charitable trusts. Is the organization filing Form 990 in lieu of Form 1041?
12a
 
 
b
If "Yes," enter the amount of tax-exempt interest received or accrued during the year. ....................
12b
 
13
Section 501(c)(29) qualified nonprofit health insurance issuers.
a
Is the organization licensed to issue qualified health plans in more than one state?
Note. See the instructions for additional information the organization must report on Schedule O.
13a
 
 
b
Enter the amount of reserves the organization is required to maintain by the states in which the organization is licensed to issue qualified health plans ....
13b
 
c
Enter the amount of reserves on hand ............
13c
 
14a
Did the organization receive any payments for indoor tanning services during the tax year?.....
14a
 
No
b
If "Yes," has it filed a Form 720 to report these payments? If "No," provide an explanation in Schedule O..
14b
 
 
Form 990 (2013)
Form 990 (2013)
Page 6
Part VI
Governance, Management, and Disclosure For each "Yes" response to lines 2 through 7b below, and for a "No" response to lines 8a, 8b, or 10b below, describe the circumstances, processes, or changes in Schedule O. See instructions.
Check if Schedule O contains a response or note to any line in this Part VI ..............
Section A. Governing Body and Management
Yes
No
1a
Enter the number of voting members of the governing body at the end of the tax year .....................
1a
13
If there are material differences in voting rights among members of the governing body, or if the governing body delegated broad authority to an executive committee or similar committee, explain in Schedule O.
b
Enter the number of voting members included in line 1a, above, who are independent ...................
1b
13
2
Did any officer, director, trustee, or key employee have a family relationship or a business relationship with any other officer, director, trustee, or key employee? .................
2
 
No
3
Did the organization delegate control over management duties customarily performed by or under the direct supervision of officers, directors or trustees, or key employees to a management company or other person? .
3
Yes
 
4
Did the organization make any significant changes to its governing documents since the prior Form 990 was filed? ...........................
4
 
No
5
Did the organization become aware during the year of a significant diversion of the organization’s assets? .
5
 
No
6
Did the organization have members or stockholders? ................
6
 
No
7a
Did the organization have members, stockholders, or other persons who had the power to elect or appoint one or more members of the governing body? ....................
7a
Yes
 
b
Are any governance decisions of the organization reserved to (or subject to approval by) members, stockholders, or persons other than the governing body? ...................
7b
Yes
 
8
Did the organization contemporaneously document the meetings held or written actions undertaken during the year by the following:
a
The governing body? .........................
8a
Yes
 
b
Each committee with authority to act on behalf of the governing body? ............
8b
Yes
 
9
Is there any officer, director, trustee, or key employee listed in Part VII, Section A, who cannot be reached at the organization’s mailing address? If "Yes," provide the names and addresses in Schedule O.......
9
 
No
Section B. Policies (This Section B requests information about policies not required by the Internal Revenue Code.)
Yes
No
10a
Did the organization have local chapters, branches, or affiliates? ............
10a
 
No
b
If "Yes," did the organization have written policies and procedures governing the activities of such chapters, affiliates, and branches to ensure their operations are consistent with the organization's exempt purposes?
10b
 
 
11a
Has the organization provided a complete copy of this Form 990 to all members of its governing body before filing the form? ............................
11a
 
No
b
Describe in Schedule O the process, if any, used by the organization to review this Form 990. .....
12a
Did the organization have a written conflict of interest policy? If "No," go to line 13.......
12a
Yes
 
b
Were officers, directors, or trustees, and key employees required to disclose annually interests that could give rise to conflicts? ..........................
12b
Yes
 
c
Did the organization regularly and consistently monitor and enforce compliance with the policy? If "Yes," describe in Schedule O how this was done.......................
12c
Yes
 
13
Did the organization have a written whistleblower policy? ...............
13
Yes
 
14
Did the organization have a written document retention and destruction policy? .........
14
Yes
 
15
Did the process for determining compensation of the following persons include a review and approval by independent persons, comparability data, and contemporaneous substantiation of the deliberation and decision?
a
The organization’s CEO, Executive Director, or top management official ...........
15a
 
 
b
Other officers or key employees of the organization ................
15b
 
 
If "Yes" to line 15a or 15b, describe the process in Schedule O (see instructions).
16a
Did the organization invest in, contribute assets to, or participate in a joint venture or similar arrangement with a taxable entity during the year? ......................
16a
 
No
b
If "Yes," did the organization follow a written policy or procedure requiring the organization to evaluate its participation in joint venture arrangements under applicable federal tax law, and take steps to safeguard the organization’s exempt status with respect to such arrangements? ............
16b
 
 
Section C. Disclosure
17
List the States with which a copy of this Form 990 is required to be filedMediumBullet
WV , WI , WA , VA , UT , TN , SC , RI , PR , PA , OR , OK , OH , NY , NJ , ND , NC , MS , MO , MN , MI , ME , MD , MA , LA , KY , KS , IL , HI , GA , FL , DC , CT , CO , CA , AZ , AR , AL , AK
18
Section 6104 requires an organization to make its Form 1023 (or 1024 if applicable), 990, and 990-T (501(c)(3)s only) available for public inspection. Indicate how you made these available. Check all that apply.
19
Describe in Schedule O whether (and if so, how) the organization made its governing documents, conflict of interest policy, and financial statements available to the public during the tax year.
20
State the name, physical address, and telephone number of the person who possesses the books and records of the organization:
MediumBulletDeborah L Johnson1701 N Beauregard StreetAlexandriaVA22311 (703) 549-1500
Form 990 (2013)
Form 990 (2013)
Page 7
Part VII
Compensation of Officers, Directors,Trustees, Key Employees, Highest Compensated Employees, and Independent Contractors
Check if Schedule O contains a response or note to any line in this Part VII ..............
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees
1a Complete this table for all persons required to be listed. Report compensation for the calendar year ending with or within the organization’s tax year.
RoundBullet List all of the organization’s current officers, directors, trustees (whether individuals or organizations), regardless of amount
of compensation. Enter -0- in columns (D), (E), and (F) if no compensation was paid.

RoundBullet List all of the organization’s current key employees, if any. See instructions for definition of "key employee."
RoundBullet List the organization’s five current highest compensated employees (other than an officer, director, trustee or key employee)
who received reportable compensation (Box 5 of Form W-2 and/or Box 7 of Form 1099-MISC) of more than $100,000 from the
organization and any related organizations.

RoundBullet List all of the organization’s former officers, key employees, or highest compensated employees who received more than $100,000
of reportable compensation from the organization and any related organizations.

RoundBullet List all of the organization’s former directors or trustees that received, in the capacity as a former director or trustee of the
organization, more than $10,000 of reportable compensation from the organization and any related organizations.

List persons in the following order: individual trustees or directors; institutional trustees; officers; key employees; highest
compensated employees; and former such persons.
Check this box if neither the organization nor any related organization compensated any current officer, director, or trustee.
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(1) Orville G Kolterman MD........................................................................
Chair of the Board
 3.00
.......................   		X   X       0 0 0
(2) Karen Talmadge PhD........................................................................
Vice Chair of the Board
 4.00
.......................   		X   X       0 0 0
(3) Pearson C Cummin III MBA........................................................................
Secretary-Treasurer
 3.00
.......................   		X   X       0 0 0
(4) Larry Hausner........................................................................
Chief Executive Officer
 2.00
.......................35.50 		X   X       0 593,656 141,375
(5) David K Bloomgarden MD FACE........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(6) John Fitzgerald III........................................................................
Board of Directors
 1.00
.......................   		X           0 0 0
(7) S Daniel Johnson........................................................................
Board of Directors
 3.00
.......................   		X           0 0 0
(8) Ralph Yates DO........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(9) Peter K Kompaniez JD........................................................................
Board of Directors
 1.00
.......................   		X           0 0 0
(10) Karmeen Kulkarni MS RD BCADM CDE........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(11) Kenneth Moritsugu MD MPH FACPM........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(12) James W Quinn........................................................................
Board of Directors
 1.00
.......................   		X           0 0 0
(13) Donald J Wagner........................................................................
Board of Directors
 3.00
.......................   		X           0 0 0
(14) Ann Juster MSW........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(15) Alvin C Powers MD........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(16) John W Griffin Jr........................................................................
Board of Directors
 2.00
.......................   		X           0 0 0
(17) Deborah L Johnson........................................................................
Chief Financial Officer
 2.00
.......................35.50 		    X       0 237,258 58,325
Form 990 (2013)
Form 990 (2013)
Page 8
Part VII
Section A. Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees (continued)
(A)
Name and Title 		(B)
Average hours per week (list any hours for related organizations below dotted line) 		(C)
Position (do not check more than one box, unless person is both an officer and a director/trustee) 		(D)
Reportable compensation from the organization (W- 2/1099-MISC) 		(E)
Reportable compensation from related organizations (W- 2/1099-MISC) 		(F)
Estimated amount of other compensation from the organization and related organizations
Individual Trustee or Director; Institutional Trustee; OfficerInd; Key Employee; Highest compensated employee; FormerOfcrDirectorTrusteeInd;
(18) Robert Ratner MD FACP FACE........................................................................
Chief Scientific Medical Officer
 2.00
.......................35.50 		    X       0 438,529 47,561
























1b Sub-Total................MediumBullet
c Total from continuation sheets to Part VII, Section A....MediumBullet
d Total (add lines 1b and 1c)............MediumBullet   1,269,443 247,261
2
Total number of individuals (including but not limited to those listed above) who received more than $100,000 of reportable compensation from the organizationMediumBullet  
Yes
No
3
Did the organization list any former officer, director or trustee, key employee, or highest compensated employee on line 1a? If "Yes," complete Schedule J for such individual ..............
3
 
No
4
For any individual listed on line 1a, is the sum of reportable compensation and other compensation from the organization and related organizations greater than $150,000? If "Yes," complete Schedule J for such individual...........................
4
Yes
 
5
Did any person listed on line 1a receive or accrue compensation from any unrelated organization or individual for services rendered to the organization? If "Yes," complete Schedule J for such person ........
5
 
No
Section B. Independent Contractors
1
Complete this table for your five highest compensated independent contractors that received more than $100,000 of compensation from the organization. Report compensation for the calendar year ending with or within the organization’s tax year.
(A)
Name and business address 		(B)
Description of services 		(C)
Compensation
NA,      
2
Total number of independent contractors (including but not limited to those listed above) who received more than $100,000 of compensation from the organization MediumBullet  
Form 990 (2013)
Form 990 (2013)
Page 9
Part VIII
Statement of Revenue
Check if Schedule O contains a response or note to any line in this Part VIII .............
(A)
Total revenue 		(B)
Related or
exempt
function
revenue 		(C)
Unrelated
business
revenue 		(D)
Revenue
excluded from
tax under sections
512-514
Contributions, Gifts, GrantAmt and OtherAmt Similar Amounts 1a Federated campaigns..1a 5,391
b Membership dues....1b  
c Fundraising events....1c  
d Related organizations...1d 37,310,310
e Government grants (contributions)1e  
f All other contributions, gifts, grants, and
similar amounts not included above1f 		3,030,145
g Noncash contributions included in lines
1a-1f:$ 		 
h Total. Add lines 1a-1f.......MediumBullet 40,345,846
Program Service RevenueAmt Business Code
2a
b
c
d
e
f All other program service revenue .        
g Total. Add lines 2a–2f........MediumBullet  
OtherAmt RevenueAmt 3 Investment income (including dividends, interest, and other similar amounts).......MediumBullet 4,222     4,222
4 Income from investment of tax-exempt bond proceeds..MediumBullet        
5 Royalties...........MediumBullet        
(i) Real (ii) Personal
6a Gross rents    
b Less: rental expenses    
c Rental income or (loss)    
d Net rental income or (loss).......MediumBullet        
(i) Securities (ii) Other
7a Gross amount from sales of assets other than inventory    
b Less: cost or other basis and sales expenses    
c Gain or (loss)    
d Net gain or (loss)..........MediumBullet        
8a Gross income from fundraising events (not including
$  
of contributions reported on line 1c). See Part IV, line 18 ..
a  
b Less: direct expenses ...b  
c Net income or (loss) from fundraising events..MediumBullet      
9a Gross income from gaming activities.
See Part IV, line 19 ...
a  
b Less: direct expenses ...b  
c Net income or (loss) from gaming activities...MediumBullet        
10a Gross sales of inventory, less
returns and allowances .
a  
b Less: cost of goods sold ..b  
c Net income or (loss) from sales of inventory..MediumBullet        
Miscellaneous Revenue Business Code
11a            
b            
c            
d All other revenue ....        
e Total. Add lines 11a–11d ...... MediumBullet  
12 Total revenue. See Instructions......MediumBullet 40,350,068     4,222
Form 990 (2013)
Form 990 (2013)
Page 10
Part IX
Statement of Functional Expenses
Section 501(c)(3) and 501(c)(4) organizations must complete all columns. All other organizations must complete column (A).Check if Schedule O contains a response or note to any line in this Part IX ...............
Do not include amounts reported on lines 6b,
7b, 8b, 9b, and 10b of Part VIII. 		(A)
Total expenses 		(B)
Program service expenses 		(C)
Management and general expenses 		(D)
Fundraising expenses
1 Grants and other assistance to governments and organizations in the United States. See Part IV, line 21 36,010,583 36,010,583
2 Grants and other assistance to individuals in the United States. See Part IV, line 22 75,000 75,000
3 Grants and other assistance to governments, organizations, and individuals outside the United States. See Part IV, lines 15 and 16 46,000 46,000
4 Benefits paid to or for members 0  
5 Compensation of current officers, directors, trustees, and key employees .... 0      
6 Compensation not included above, to disqualified persons (as defined under section 4958(f)(1)) and persons described in section 4958(c)(3)(B) .... 0      
7 Other salaries and wages 0      
8 Pension plan accruals and contributions (include section 401(k) and 403(b) employer contributions) .... 0      
9 Other employee benefits ....... 0      
10 Payroll taxes ........... 0      
11 Fees for services (non-employees):        
a Management ...... 1,308,995   490,873 818,122
b Legal ......... 0      
c Accounting ........... 0      
d Lobbying ........... 0      
e Professional fundraising services. See Part IV, line 17    
f Investment management fees ...... 0      
g Other (If line 11g amount exceeds 10% of line 25, column (A) amount, list line 11g expenses on Schedule O) ........ 0      
12 Advertising and promotion .... 0      
13 Office expenses ....... 0      
14 Information technology ...... 0      
15 Royalties .. 0      
16 Occupancy ........... 0      
17 Travel ............ 0      
18 Payments of travel or entertainment expenses for any federal, state, or local public officials ...... 0      
19 Conferences, conventions, and meetings .... 0      
20 Interest ........... 0      
21 Payments to affiliates ....... 0      
22 Depreciation, depletion, and amortization ..... 0      
23 Insurance .............. 0      
24 Other expenses. Itemize expenses not covered above (List miscellaneous expenses in line 24e. If line 24e amount exceeds 10% of line 25, column (A) amount, list line 24e expenses on Schedule O.)
a
b
c
d
e All other expenses 0      
25 Total functional expenses. Add lines 1 through 24e 37,440,578 36,131,583 490,873 818,122
26 Joint costs. Complete this line only if the organization reported in column (B) joint costs from a combined educational campaign and fundraising solicitation. Check here MediumBullet if following SOP 98-2 (ASC 958-720).        
Form 990 (2013)
Form 990 (2013)
Page 11
Part X Balance Sheet Check if Schedule O contains a response or note to any line in this Part X ..............
(A)
Beginning of year 		(B)
End of year
Assets 1 Cash–non-interest-bearing .............   1  
2 Savings and temporary cash investments ......... 729,908 2 202,235
3 Pledges and grants receivable, net ........... 34,340,604 3 40,971,457
4 Accounts receivable, net .............   4  
5 Loans and other receivables from current and former officers, directors, trustees, key employees, and highest compensated employees. Complete Part II of
Schedule L ..................
  5  
6 Loans and other receivables from other disqualified persons (as defined under section 4958(f)(1)), persons described in section 4958(c)(3)(B), and contributing employers and sponsoring organizations of section 501(c)(9) voluntary employees' beneficiary organizations (see instructions) Complete Part II of Schedule L
  6  
7 Notes and loans receivable, net .............   7  
8 Inventories for sale or use ..............   8  
9 Prepaid expenses and deferred charges ..........   9  
10a Land, buildings, and equipment: cost or other basis. Complete Part VI of Schedule D 10a  
b Less: accumulated depreciation ..... 10b     10c  
11 Investments—publicly traded securities ..........   11  
12 Investments—other securities. See Part IV, line 11 ..... 84,176 12 85,646
13 Investments—program-related. See Part IV, line 11 .....   13  
14 Intangible assets ...............   14  
15 Other assets. See Part IV, line 11 ...........   15  
16 Total assets. Add lines 1 through 15 (must equal line 34)...... 35,154,688 16 41,259,338
Liabilities 17 Accounts payable and accrued expenses .........   17  
18 Grants payable ................. 10,265,209 18 12,833,035
19 Deferred revenue ................   19  
20 Tax-exempt bond liabilities .............   20  
21 Escrow or custodial account liability. Complete Part IV of Schedule D..   21  
22 Loans and other payables to current and former officers, directors, trustees, key employees, highest compensated employees, and disqualified
persons. Complete Part II of Schedule L..........   22  
23 Secured mortgages and notes payable to unrelated third parties ..   23  
24 Unsecured notes and loans payable to unrelated third parties ....   24  
25 Other liabilities (including federal income tax, payables to related third parties, and other liabilities not included on lines 17-24). Complete Part X of Schedule D....................   25  
26 Total liabilities. Add lines 17 through 25......... 10,265,209 26 12,833,035
Net Assets or Fund Balance Organizations that follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 27 through 29, and lines 33 and 34.
27 Unrestricted net assets ..............   27  
28 Temporarily restricted net assets ........... 24,805,303 28 28,340,657
29 Permanently restricted net assets ........... 84,176 29 85,646
Organizations that do not follow SFAS 117 (ASC 958), check here MediumBullet and complete lines 30 through 34.
30 Capital stock or trust principal, or current funds ........   30  
31 Paid-in or capital surplus, or land, building or equipment fund .....   31  
32 Retained earnings, endowment, accumulated income, or other funds   32  
33 Total net assets or fund balances ........... 24,889,479 33 28,426,303
34 Total liabilities and net assets/fund balances ........ 35,154,688 34 41,259,338
Form 990 (2013)
Form 990 (2013)
Page 12
Part XI
Reconcilliation of Net Assets
Check if Schedule O contains a response or note to any line in this Part XI ..............
1
Total revenue (must equal Part VIII, column (A), line 12) ............
1
40,350,068
2
Total expenses (must equal Part IX, column (A), line 25) ............
2
37,440,578
3
Revenue less expenses. Subtract line 2 from line 1 ..............
3
2,909,490
4
Net assets or fund balances at beginning of year (must equal Part X, line 33, column (A)) ..
4
24,889,479
5
Net unrealized gains (losses) on investments ...............
5
1,470
6
Donated services and use of facilities .................
6
 
7
Investment expenses .....................
7
 
8
Prior period adjustments .....................
8
 
9
Other changes in net assets or fund balances (explain in Schedule O) ........
9
625,864
10
Net assets or fund balances at end of year. Combine lines 3 through 9 (must equal Part X, line 33, column (B))
10
28,426,303
Part XII
Financial Statements and Reporting
Check if Schedule O contains a response or note to any line in this Part XII .............
Yes
No
1
Accounting method used to prepare the Form 990:  
If the organization changed its method of accounting from a prior year or checked "Other," explain in
Schedule O.
2a
Were the organization’s financial statements compiled or reviewed by an independent accountant?
2a
 
No
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were compiled or reviewed on a separate basis, consolidated basis, or both:
b
Were the organization’s financial statements audited by an independent accountant?
2b
Yes
 
If ‘Yes,’ check a box below to indicate whether the financial statements for the year were audited on a separate basis, consolidated basis, or both:
c
If "Yes," to line 2a or 2b, does the organization have a committee that assumes responsibility for oversight of the audit, review, or compilation of its financial statements and selection of an independent accountant?
2c
Yes
 
If the organization changed either its oversight process or selection process during the tax year, explain in Schedule O.
3a
As a result of a federal award, was the organization required to undergo an audit or audits as set forth in the Single Audit Act and OMB Circular A-133?
3a
 
No
b
If "Yes," did the organization undergo the required audit or audits? If the organization did not undergo the required audit or audits, explain why in Schedule O and describe any steps taken to undergo such audits.
3b
 
 
Form 990 (2013)
Form 990, Special Condition Description:
Special Condition Description
Additional Data


Software ID: 13000230
Software Version: 13.6.0.0
SCHEDULE A
(Form 990 or 990EZ)

Department of the Treasury
Internal Revenue Service
Public Charity Status and Public Support
Complete if the organization is a section 501(c)(3) organization or a section 4947(a)(1) nonexempt charitable trust.
right arrow Attach to Form 990 or Form 990-EZ. right arrow See separate instructions.
right arrow Information about Schedule A (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public
Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
Reason for Public Charity Status (All organizations must complete this part.) See instructions.
The organization is not a private foundation because it is: (For lines 1 through 11, check only one box.)
1
2
3
4
5
section 170(b)(1)(A)(iv). (Complete Part II.)
6
7
8
9
receipts from activities related to its exempt functions—subject to certain exceptions, and (2) no more than 331/3% of
its support from gross investment income and unrelated business taxable income (less section 511 tax) from businesses
acquired by the organization after June 30, 1975. See section 509(a)(2). (Complete Part III.)
10
11
e
f
g
(i) A person who directly or indirectly controls, either alone or together with persons described in (ii)
Yes
No
and (iii) below, the governing body of the supported organization? ................
11g(i)
 
 
(ii) A family member of a person described in (i) above? ......................
11g(ii)
 
 
(iii) A 35% controlled entity of a person described in (i) or (ii) above? ................
11g(iii)
 
 
h
Provide the following information about the supported organization(s).
(i) Name of supported organization (ii) EIN (iii) Type of organization (described on lines 1- 9 above or IRC section (see instructions)) (iv) Is the organization in col. (i) listed in your governing document? (v) Did you notify the organization in col. (i) of your support? (vi) Is the organization in col. (i) organized in the U.S.? (vii) Amount of monetary support
Yes No Yes No Yes No
Total  

For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990EZ.
Cat. No. 11285F
Schedule A (Form 990 or 990-EZ) 2013
Schedule A (Form 990 or 990-EZ) 2013
Page 2
Part II
Support Schedule for Organizations Described in Sections 170(b)(1)(A)(iv) and 170(b)(1)(A)(vi)
(Complete only if you checked the box on line 5, 7, or 8 of Part I or if the organization failed to qualify under Part III. If the organization fails to qualify under the tests listed below, please complete Part III.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2009 (b) 2010 (c) 2011 (d) 2012 (e) 2013 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .... 35,815,958 36,423,872 34,135,315 55,590,601 40,345,846 202,311,592
2 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.......            
3 The value of services or facilities furnished by a governmental unit to the organization without charge..            
4 Total. Add lines 1 through 3 35,815,958 36,423,872 34,135,315 55,590,601 40,345,846 202,311,592
5 The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. 7,945,220
6 Public support. Subtract line 5 from line 4. 194,366,372
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2009 (b) 2010 (c) 2011 (d) 2012 (e) 2013 (f) Total
7 Amounts from line 4.. 35,815,958 36,423,872 34,135,315 55,590,601 40,345,846 202,311,592
8 Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... 193 1,979 1,753 3,388 4,222 11,535
9 Net income from unrelated business activities, whether or not the business is regularly carried on..            
10 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.)..            
11 Total support (Add lines 7 through 10). 202,323,127
12
12
 
13
First five years. If the Form 990 is for the organization's first, second, third, fourth, or fifth tax year as a 501(c)(3) organization, check this box and stop here.................................................right arrow
Section C. Computation of Public Support Percentage
14
14
96.070 %
15
15
95.760 %
16a
b
17a
b
18
Private foundation. If the organization did not check a box on line 13, 16a, 16b, 17a, or 17b, check this box and see
instructions ..................................................... right arrow
Schedule A (Form 990 or 990-EZ) 2013
Schedule A (Form 990 or 990-EZ) 2013
Page 3
Part III
Support Schedule for Organizations Described in Section 509(a)(2)
(Complete only if you checked the box on line 9 of Part I or if the organization failed to qualify under Part II. If the organization fails to qualify under the tests listed below, please complete Part II.)
Section A. Public Support
Calendar year (or fiscal year beginning in) right arrow (a) 2009 (b) 2010 (c) 2011 (d) 2012 (e) 2013 (f) Total
1 Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") .            
2 Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose......            
3 Gross receipts from activities that are not an unrelated trade or business under section 513..            
4 Tax revenues levied for the organization's benefit and either paid to or expended on its behalf...            
5 The value of services or facilities furnished by a governmental unit to the organization without charge..            
6 Total. Add lines 1 through 5.            
7a Amounts included on lines 1, 2, and 3 received from disqualified persons...            
b Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year.            
c Add lines 7a and 7b..            
8 Public support (Subtract line 7c from line 6.)  
Section B. Total Support
Calendar year (or fiscal year beginning in) right arrow (a) 2009 (b) 2010 (c) 2011 (d) 2012 (e) 2013 (f) Total
9 Amounts from line 6...            
10a Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources..            
b Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975.            
c Add lines 10a and 10b.            
11 Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on.            
12 Other income. Do not include gain or loss from the sale of capital assets (Explain in Part IV.) ..            
13 Total support. (Add lines 9, 10c, 11, and 12.)..            
14
Section C. Computation of Public Support Percentage
15
15
0 %
16
16
 
Section D. Computation of Investment Income Percentage
17
17
0 %
18
18
 
19a
b
20
Schedule A (Form 990 or 990-EZ) 2013
Schedule A (Form 990 or 990-EZ) 2013
Page 4
Part IV
Supplemental Information. Provide the explanations required by Part II, line 10; Part II, line 17a or 17b; and Part III, line 12. Also complete this part for any additional information. (See instructions).
Facts And Circumstances Test
 
Explanation
 
 
 
 
Schedule A (Form 990 or 990-EZ) 2013

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0
Schedule B
(Form 990, 990-EZ,
or 990-PF)
Department of the Treasury
Internal Revenue Service
Schedule of Contributors
Arrow Bullet Attach to Form 990, 990-EZ, or 990-PF.
Arrow Bullet Information about Schedule B (Form 990, 990-EZ, or 990-PF) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Organization type (check one):
Filers of:
Section:
Form 990 or 990-EZ





Form 990-PF




Check if your organization is covered by the General Rule or a Special Rule.  
Note. Only a section 501(c)(7), (8), or (10) organization can check boxes for both the General Rule and a Special Rule. See instructions.
General Rule
Special Rules
......................... Arrow Bullet $  
Caution. An organization that is not covered by the General Rule and/or the Special Rules does not file Schedule B (Form 990,
990-EZ, or 990-PF), but it must answer “No” on Part IV, line 2, of its Form 990; or check the box on line H of its
Form 990-EZ or on its Form 990PF, Part I, line 2, to certify that it does not meet the filing requirements of Schedule B (Form 990,
990-EZ, or 990-PF).
For Paperwork Reduction Act Notice, see the Instructions
for Form 990, 990-EZ, or 990-PF.
Cat. No. 30613XSchedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)
Page 2
Name of organization
American Diabetes Association Research Foundation Inc
  		Employer identification number

54-1734511
Part I
Contributors (see instructions). Use duplicate copies of Part I if additional space is needed.
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
RESTRICTED
RESTRICTED
 

   
RESTRICTED
RESTRICTED
RESTRICTED, RESTRICTEDRESTRICTED

$RESTRICTED


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
(a)
No.		 (b)
Name, address, and ZIP + 4		 (c)
Total contributions		 (d)
Type of contribution
 
 
 

   
 
 

$  


(Complete Part II for noncash contributions.)
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)
Page 3
Name of organization
American Diabetes Association Research Foundation Inc
  		Employer identification number

54-1734511
Part II
Noncash Property (see instructions). Use duplicate copies of Part II if additional space is needed.
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
(a) No.
from
Part I		 (b)
Description of noncash property given		 (c)
FMV (or estimate)
(see instructions) 		(d)
Date received
 
$    
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Schedule B (Form 990, 990-EZ, or 990-PF) (2013)
Page 4
Name of organization
American Diabetes Association Research Foundation Inc
  		Employer identification number

54-1734511
Part III
Exclusively religious, charitable, etc., individual contributions to section 501(c)(7), (8), or (10) organizations
that total more than $1,000 for the year. Complete columns (a) through (e) and the following line entry.
For organizations completing Part III, enter the total of exclusively religious, charitable, etc.,
contributions of $1,000 or less for the year. (Enter this information once. See instructions.) Arrow Bullet$  
Use duplicate copies of Part III if additional space is needed.
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
(a) No.
from
Part I		 (b) Purpose of gift (c) Use of gift (d) Description of how gift is held
 
(e) Transfer of gift
Transferee's name, address, and ZIP 4 Relationship of transferor to transferee
 
 
     
 
Schedule B (Form 990, 990-EZ, or 990-PF) (2013)

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0
SCHEDULE D
(Form 990)
Department of the Treasury
Internal Revenue Service
Supplemental Financial Statements
SchDMd Bullet Complete if the organization answered "Yes," to Form 990,
Part IV, line 6, 7, 8, 9, 10, 11a, 11b, 11c, 11d, 11e, 11f, 12a, or 12b
SchDMd Bullet Attach to Form 990. SchDMd Bullet See separate instructions. SchDMd Bullet Information about Schedule D (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
Organizations Maintaining Donor Advised Funds or Other Similar Funds or Accounts. Complete if the organization answered "Yes" to Form 990, Part IV, line 6.
(a) Donor advised funds (b) Funds and other accounts
1 Total number at end of year .........    
2 Aggregate contributions to (during year) ...    
3 Aggregate grants from (during year) .....    
4 Aggregate value at end of year ........    
5
Did the organization inform all donors and donor advisors in writing that the assets held in donor advised
funds are the organization's property, subject to the organization's exclusive legal control? ............
6
Did the organization inform all grantees, donors, and donor advisors in writing that grant funds can be
used only for charitable purposes and not for the benefit of the donor or donor advisor, or for any other purpose conferring impermissible private benefit? ...................................
Part II
Conservation Easements. Complete if the organization answered "Yes" to Form 990, Part IV, line 7.
1
Purpose(s) of conservation easements held by the organization (check all that apply).
2
Complete lines 2a through 2d if the organization held a qualified conservation contribution in the form of a conservation easement on the last day of the tax year.
Held at the End of the Year
a Total number of conservation easements ....................... 2a  
b Total acreage restricted by conservation easements .................. 2b  
c Number of conservation easements on a certified historic structure included in (a) ..... 2c  
d Number of conservation easements included in (c) acquired after 8/17/06, and not on a historic structure listed in the National Register .................... 2d  
3
Number of conservation easements modified, transferred, released, extinguished, or terminated by the organization during
the tax year SchDMd Bullet  
4
Number of states where property subject to conservation easement is located SchDMd Bullet  
5
Does the organization have a written policy regarding the periodic monitoring, inspection, handling of violations, and
enforcement of the conservation easements it holds? .............................
6
Staff and volunteer hours devoted to monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet  
7
Amount of expenses incurred in monitoring, inspecting, and enforcing conservation easements during the year
SchDMd Bullet $  
8
Does each conservation easement reported on line 2(d) above satisfy the requirements of section 170(h)(4)(B)(i) and section 170(h)(4)(B)(ii)? .......................................
9
In Part XIII, describe how the organization reports conservation easements in its revenue and expense statement, and
balance sheet, and include, if applicable, the text of the footnote to the organization’s financial statements that describes
the organization’s accounting for conservation easements.
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets.
Complete if the organization answered "Yes" to Form 990, Part IV, line 8.
1a
If the organization elected, as permitted under SFAS 116 (ASC 958), not to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide, in Part XIII, the text of the footnote to its financial statements that describes these items.
b
If the organization elected, as permitted under SFAS 116 (ASC 958), to report in its revenue statement and balance sheet works of art, historical treasures, or other similar assets held for public exhibition, education, or research in furtherance of public service, provide the following amounts relating to these items:
(i)
Revenues included in Form 990, Part VIII, line 1 ........................SchDMd Bullet $  
(ii)
Assets included in Form 990, Part X ..............................SchDMd Bullet $  
2
If the organization received or held works of art, historical treasures, or other similar assets for financial gain, provide the
following amounts required to be reported under SFAS 116 (ASC 958) relating to these items:
a
Revenues included in Form 990, Part VIII, line 1 ..........................SchDMd Bullet $  
b
Assets included in Form 990, Part X ...............................SchDMd Bullet $  
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 52283D
Schedule D (Form 990) 2013

Schedule D (Form 990) 2013
Page 2
Part III
Organizations Maintaining Collections of Art, Historical Treasures, or Other Similar Assets (continued)
3
Using the organization’s acquisition, accession, and other records, check any of the following that are a significant use of its collection items (check all that apply):
a
d
b
e
 
c
4
Provide a description of the organization’s collections and explain how they further the organization’s exempt purpose in
Part XIII.
5
During the year, did the organization solicit or receive donations of art, historical treasures or other similar
assets to be sold to raise funds rather than to be maintained as part of the organization’s collection?........
Part IV
Escrow and Custodial Arrangements. Complete if the organization answered "Yes" to Form 990,
Part IV, line 9, or reported an amount on Form 990, Part X, line 21.
1a
Is the organization an agent, trustee, custodian or other intermediary for contributions or other assets not
included on Form 990, Part X? ....................................
b
If "Yes," explain the arrangement in Part XIII and complete the following table:
Amount
c Beginning balance ................................. 1c  
d Additions during the year .............................. 1d  
e Distributions during the year ............................. 1e  
f Ending balance ................................... 1f  
2a
Did the organization include an amount on Form 990, Part X, line 21? .....................
b
If "Yes," explain the arrangement in Part XIII. Check here if the explanation has been provided in Part XIII ........
Part V
Endowment Funds. Complete if the organization answered "Yes" to Form 990, Part IV, line 10.
(a)Current year (b)Prior year b (c)Two years back (d)Three years back (e)Four years back
1a Beginning of year balance ....          
b Contributions ........          
c Net investment earnings, gains, and losses          
d Grants or scholarships .....          
e Other expenditures for facilities
and programs ........ 		         
f Administrative expenses ....          
g End of year balance ......          
2
Provide the estimated percentage of the current year end balance (line 1g, column (a)) held as:
a
Board designated or quasi-endowment SchDMd Bullet  
b
Permanent endowment SchDMd Bullet  
c
Temporarily restricted endowment SchDMd Bullet  
The percentages in lines 2a, 2b, and 2c should equal 100%.
3a
Are there endowment funds not in the possession of the organization that are held and administered for the
organization by:

Yes
No
(i) unrelated organizations ........................
3a(i)
 
 
(ii) related organizations ........................
3a(ii)
 
 
b
If "Yes" to 3a(ii), are the related organizations listed as required on Schedule R? .........
3b
 
 
4
Describe in Part XIII the intended uses of the organization's endowment funds.
Part VI
Land, Buildings, and Equipment. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11a. See Form 990, Part X, line 10.
Description of property (a) Cost or other basis (investment) (b)Cost or other basis (other) (c) Accumulated depreciation (d) Book value
1a Land .................      
b Buildings ................        
c Leasehold improvements ............        
d Equipment ................        
e Other .................        
Total. Add lines 1a through 1e. (Column (d) must equal Form 990, Part X, column (B), line 10(c).).......SchDMdBullet  
Schedule D (Form 990) 2013

Schedule D (Form 990) 2013
Page 3
Part VII
Investments—Other Securities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11b. See Form 990, Part X, line 12.
(a) Description of security or category
(including name of security)		 (b)Book value (c) Method of valuation:
Cost or end-of-year market value
(1)Financial derivatives    
(2)Closely-held equity interests    
(3)Other
(A) Financial derivatives and other financial products 		   

(B) Closely-held equity interests 		   







Total. (Column (b) must equal Form 990, Part X, col. (B) line 12.)Small Bullet  
Part VIII
Investments—Program Related. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11c. See Form 990, Part X, line 13.
(a) Description of investment (b) Book value (c) Method of valuation:
Cost or end-of-year market value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 13.)Small Bullet  
Part IX
Other Assets. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11d. See Form 990, Part X, line 15.
(a) Description (b) Book value








Total. (Column (b) must equal Form 990, Part X, col.(B) line 15.)...........Small Bullet  
Part X
Other Liabilities. Complete if the organization answered 'Yes' to Form 990, Part IV, line 11e or 11f. See Form 990, Part X, line 25.
1.(a) Description of liability (b) Book value
Federal income taxes  
Federal income taxes  








Total. (Column (b) must equal Form 990, Part X, col.(B) line 25.)Small Bullet  
2. Liability for uncertain tax positions In Part XIII, provide the text of the footnote to the organization's financial statements that reports the organization's liability for uncertain tax positions under FIN 48 (ASC 740). Check here if the text of the footnote has been provided in Part XIII ..................................................
Schedule D (Form 990) 2013

Schedule D (Form 990) 2013
Page 4
Part XI Reconciliation of Revenue per Audited Financial Statements With Revenue per Return Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1 Total revenue, gains, and other support per audited financial statements ....... 1 41,058,233
2 Amounts included on line 1 but not on Form 990, Part VIII, line 12:
a Net unrealized gains on investments .......... 2a 1,470
b Donated services and use of facilities ......... 2b 706,695
c Recoveries of prior year grants ........... 2c  
d Other (Describe in Part XIII.) ............ 2d  
e Add lines 2a through 2d ..................... 2e 708,165
3 Subtract line 2e from line 1..................... 3 40,350,068
4 Amounts included on Form 990, Part VIII, line 12, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b . 4a  
b Other (Describe in Part XIII.) ........... 4b  
c Add lines 4a and 4b....................... 4c  
5 Total revenue. Add lines 3 and 4c. (This must equal Form 990, Part I, line 12.) ...... 5 40,350,068
Part XII Reconciliation of Expenses per Audited Financial Statements With Expenses per Return. Complete if the organization answered 'Yes' to Form 990, Part IV, line 12a.
1 Total expenses and losses per audited financial statements ........... 1 37,521,409
2 Amounts included on line 1 but not on Form 990, Part IX, line 25:
a Donated services and use of facilities .......... 2a 706,695
b Prior year adjustments .............. 2b  
c Other losses ................ 2c  
d Other (Describe in Part XIII.) ............ 2d -625,864
e Add lines 2a through 2d...................... 2e 80,831
3 Subtract line 2e from line 1..................... 3 37,440,578
4 Amounts included on Form 990, Part IX, line 25, but not on line 1:
a Investment expenses not included on Form 990, Part VIII, line 7b .. 4a  
b Other (Describe in Part XIII.) ............ 4b  
c Add lines 4a and 4b....................... 4c  
5 Total expenses. Add lines 3 and 4c. (This must equal Form 990, Part I, line 18.) ...... 5 37,440,578
Part XIII
Supplemental Information
Provide the descriptions required for Part II, lines 3, 5, and 9; Part III, lines 1a and 4; Part lV, lines 1b and 2b;
Part V, line 4; Part X, line 2; Part XI, lines 2d and 4b; and Part XII, lines 2d and 4b. Also complete this part to provide any additional information.
Return Reference Explanation
X 2 The following was disclosed related to uncertain tax positions in the audited financial statements. The American Diabetes Association Research Foundation, Inc. is exempt from income taxes under Section 501c3 of the Internal Revenue Code the Code and charitable contributions to the Foundation qualify for charitable tax deductions as described in the Code. The Foundation has been classified as an organization that is not a private foundation under Section 509a of the Code. The Foundation recognizes the effect of income tax positions only if those positions more likely than not would not be sustained upon examination by the Internal Revenue Services. The Foundation has analyzed the tax positions taken and has concluded that as of December 31, 2013, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or asset or disclosure in the financial statements.
XII 2d Prior Year Research Grants Awards Refunds/Forfeitures 625,864.
Schedule D (Form 990) 2013

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0




SCHEDULE F(Form 990)
Department of the Treasury
Internal Revenue Service
Statement of Activities Outside the United States
Right pointing arrow large image Complete if the organization answered "Yes" to Form 990,Part IV, line 14b, 15, or 16.Right pointing arrow large image Attach to Form 990. Right pointing arrow large image See separate instructions.Right pointing arrow large image Information about Schedule F (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
General Information on Activities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 14b.
1
For grantmakers.Does the organization maintain records to substantiate the amount of its grants and
other assistance, the grantees’ eligibility for the grants or assistance, and the selection criteria used
to award the grants or assistance? ...............................
2
For grantmakers. Describe in Part V the organization’s procedures for monitoring the use of its grants and other assistance outside the United States.
3
Activites per Region. (The following Part I, line 3 table can be duplicated if additional space is needed.)
(a) Region (b) Number of offices in the region (c) Number of employees, agents, and independent contractors in region (d) Activities conducted in region (by type) (e.g., fundraising, program services, investments, grants to recipients located in the region) (e) If activity listed in (d) is a program service, describe specific type of
service(s) in region		 (f) Total expenditures
for and investments
in region
North America     Program Services Research grants 46,000
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
3a Sub-total .....     46,000
b Total from continuation sheets to Part I ...      
c Totals (add lines 3a and 3b)     46,000
For Paperwork Reduction Act Notice, see the Instructions for Form 990.Cat. No. 50082W Schedule F (Form 990) 2013
Schedule F (Form 990) 2013
Page 2
Part II
Grants and Other Assistance to Organizations or Entities Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 15, for any recipient who received more than $5,000. Part II can be duplicated if additional space is needed.
1 (a) Name of organization (b) IRS code section
and EIN (if applicable)		 (c) Region (d) Purpose of
grant 		(e) Amount of
cash grant 		(f) Manner of
cash
disbursement 		(g) Amount
of non-cash
assistance 		(h) Description
of non-cash
assistance 		(i) Method of
valuation
(book, FMV,
appraisal, other)
North America Diabetes research grant support to the Canadian Diabetes Association 46,000 Check      
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
2 Enter total number of recipient organizations listed above that are recognized as charities by the foreign country, recognized as tax-exempt by the IRS, or for which the grantee or counsel has provided a section 501(c)(3) equivalency letter ....MediumBullet
1
3
Enter total number of other organizations or entities .......................MediumBullet
 
Schedule F (Form 990) 2013
Schedule F (Form 990) 2013Page 3
Part III
Grants and Other Assistance to Individuals Outside the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 16.
Part III can be duplicated if additional space is needed.
(a) Type of grant or assistance (b) Region (c) Number of recipients (d) Amount of
cash grant 		(e) Manner of cash
disbursement 		(f) Amount of
non-cash
assistance 		(g) Description
of non-cash
assistance 		(h) Method of
valuation
(book, FMV,
appraisal, other)
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
               
Schedule F (Form 990) 2013
Schedule F (Form 990) 2013
Page 4
Part IV
Foreign Forms
1 Was the organization a U.S. transferor of property to a foreign corporation during the tax year? If "Yes,"the organization may be required to file Form 926, Return by a U.S. Transferor of Property to a Foreign Corporation (see Instructions for Form 926)......................................
2 Did the organization have an interest in a foreign trust during the tax year? If "Yes," the organization may be required to file Form 3520, Annual Return to Report Transactions with Foreign Trusts and Receipt of Certain Foreign Gifts, and/or Form 3520-A, Annual Information Return of Foreign Trust With a U.S. Owner (see Instructions for Forms 3520 and 3520-A).......................................
3 Did the organization have an ownership interest in a foreign corporation during the tax year? If "Yes," the organization may be required to file Form 5471, Information Return of U.S. Persons with Respect to Certain Foreign Corporations. (see Instructions for Form 5471)..............................
4 Was the organization a direct or indirect shareholder of a passive foreign investment company or a qualified electing fund during the tax year? If “Yes,” the organization may be required to file Form 8621, Information Return by a Shareholder of a Passive Foreign Investment Company or Qualified Electing Fund. (see Instructions for Form 8621)...............................................
5 Did the organization have an ownership interest in a foreign partnership during the tax year? If "Yes," the organization may be required to file Form 8865, Return of U.S. Persons with Respect to Certain Foreign Partnerships. (see Instructions for Form 8865)....................................
6 Did the organization have any operations in or related to any boycotting countries during the tax year? If "Yes," the organization may be required to file Form 5713, International Boycott Report (see Instructions for Form 5713)................................................
Schedule F (Form 990) 2013
Schedule F (Form 990) 2013
Page 5
Part V
Supplemental Information
Provide the information required by Part I, line 2 (monitoring of funds); Part I, line 3, column (f) (accounting method; amounts of investments vs. expenditures per region); Part II, line 1 (accounting method); Part III (accounting method); and Part III, column (c) (estimated number of recipients), as applicable. Also complete this part to provide any additional information (see instructions).
ReturnReference Explanation
Part I Line 1,2 The American Diabetes Association and the Canadian Diabetes Association CDA initiated a joint partnership in support of a Post-Doctoral fellowship. The program is designed to encourage international training of diabetes researchers. The program provides training grants for U.S. post-doctoral fellows in diabetes research performing their work in Canada, as well as Canadian fellows carrying out their fellowship work in the U.S. Also, it encourages international scientific discourse. Research awards are administered through the Canadian Diabetes Association. Each grantee is required to submit a detailed annual progress report to CDA which includes a scientific and financial portion, 75 days after the end of each previously committed funding year. Cumulative final report is required within 6 months after the expiration date of the grant. If the progress report is not received by the due date, all subsequent award payments will be delayed until the obligations for the award are complete.
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
Schedule F (Form 990) 2013
Additional Data


Software ID: 13000230
Software Version: 13.6.0.0



Schedule I
(Form 990)
Department of the Treasury
Internal Revenue Service
Grants and Other Assistance to Organizations,
Governments and Individuals in the United States
Complete if the organization answered "Yes," to Form 990, Part IV, line 21 or 22.
lBullet Attach to Form 990
lBullet Information about Schedule I (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public
Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number
54-1734511
Part I
General Information on Grants and Assistance
1
Does the organization maintain records to substantiate the amount of the grants or assistance, the grantees' eligibility for the grants or assistance, and
the selection criteria used to award the grants or assistance? ....................................
2
Describe in Part IV the organization's procedures for monitoring the use of grant funds in the United States.
Part II
Grants and Other Assistance to Governments and Organizations in the United States. Complete if the organization answered "Yes" to
Form 990, Part IV, line 21, for any recipient that received more than $5,000. Part II can be duplicated if additional space is needed.
(a) Name and address of organization
or government		 (b) EIN (c) IRC Code section
if applicable		 (d) Amount of cash grant (e) Amount of non-cash
assistance		 (f) Method of valuation
(book, FMV, appraisal,
other)		 (g) Description of
non-cash assistance		 (h) Purpose of grant
or assistance
(1) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 100,000       ADA Ethicon Covidien - Basic
(2) University of Utah
201 South Presidents Circle Rm 406
Salt Lake City,UT84112 		87-6000525 501 c3 199,868       ADA Ethicon Covidien - Clinical
(3) University of Southern California
1540 Alcazar Street CHP 100
Los Angeles,CA90033 		95-1642394 501 c3 22,500       ADA-APMA Fellowship Award
(4) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 12,500       ADA-ASP T. Franklin Williams Scholars Award
(5) The Regents of the University of California Davis
One Shields Avenue
Davis,CA95616 		94-6036494 501 c3 122,145       ADA-GlaxoSmithKline Award
(6) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 250,000       ADA-GlaxoSmithKline Award
(7) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 200,000       ADA-GlaxoSmithKline Award
(8) National Institutes of Health NIDDK DECRS
9000 Rockville Pike Building 31 Roo
Bethesda,MD20892 		52-0858115 170 c1 26,187       ADA-JDRF Genetics of Nephropathy
(9) University of Pennsylvania
3451 Walnut St P-221 Frankin Buildi
Philadelphia,PA19104 		23-1352685 501 c3 172,796       ADA-JDRF Genetics of Nephropathy
(10) Biomedical Research Institute of New Mexico (BRINM)
1501 San Pedro SE Bulding 14151
Albuquerque,NM87108 		85-0374063 501 c3 188,078       ADA-Lilly Clinical Research Award
(11) Emory University School of Medicine
1599 Clifton Road NE 4th Floor MAIL
Atlanta,GA30322 		58-0566256 501 c3 190,000       ADA-Lilly Clinical Research Award
(12) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 35,000       ADA-Medtronic Technology in Diabetes Fellowship
(13) Carl T Hayden Veterans Affairs Medical Center
650 E Indian School Road
Phoenix,AZ85012 		86-0907729 501 c3 75,000       ADA-Merck Clinical/Translational Postdoctoral Fellowship Award
(14) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 62,070       ADA-Merck Clinical/Translational Postdoctoral Fellowship Award
(15) Emory University School of Medicine
1599 Clifton Road NE 4th Floor MAIL
Atlanta,GA30322 		58-0566256 501 c3 168,929       ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(16) Massachusetts General Hospital
50 Staniford Street 10th Floor
Boston,MA02214 		04-2697983 501 c3 168,143       ADA-Novo Nordisk Award in Hypoglycemia in Diabetes
(17) Stanford University School of Medicine
300 Pasteur Drive
Stanford,CA94305 		94-1156365 501 c3 200,000       ADA-Novo Nordisk Award in Neurohormonal Control of Metabolism
(18) The Regents of the University of California San Francisco
3333 California Street Ste 315
San Francisco,CA94143 		94-6036493 501 c3 150,000       ADA-Novo Nordisk Award in Neurohormonal Control of Metabolism
(19) University of Pittsburgh
116 Atwood Street Suite 201
Pittsburg,PA15260 		25-0965591 501 c3 235,414       ADA-Sanofi-Aventis U.S. Award in Health Services Research in Clinical Care Delivery in Diabetes
(20) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 250,000       ADA-Sanofi-Aventis U.S. Award in Health Services Research in Clinical Care Delivery in Diabetes
(21) Albert Einstein College of Medicine
1300 Morris Park Ave
Bronx,NY10461 		13-1624225 501 c3 207,000       Basic Science
(22) Auburn University
321 Ingram Hall
Auburn University,AL36849 		63-6000724 501 c3 103,500       Basic Science
(23) Beth Israel Deaconess Medical Center
330 Brookline Ave E BR-259
Boston,MA02219 		04-2103881 501 c3 414,000       Basic Science
(24) Burke-Cornell Medical Research Institute
785 Mamaroneck Avenue
White Plains,NY10605 		13-3434924 501 c3 102,991       Basic Science
(25) Case Western Reserve University
10900 Euclid Avenue
Cleveland,OH44106 		34-1018992 501 c3 103,500       Basic Science
(26) College of Staten Island City University of New York
2800 Victory Boulevard Rm 1C-202
Staten Island,NY10314 		13-2933777 501 c3 89,390       Basic Science
(27) Duke University
324 Blackwell St Washington Bldg
Durham,NC27701 		56-0532129 501 c3 103,500       Basic Science
(28) Georgia State University Research Foundation Inc
POBox 3999
Atlanta,GA30302 		58-1845423 501 c3 103,500       Basic Science
(29) Joslin Diabetes Center
One Joslin Place
Boston,MA02215 		04-2203836 501 c3 310,500       Basic Science
(30) Los Angeles Biomedical Research Institute
1124 West Carson Street Bldg N-16
Torrance,CA90502 		95-2138184 501 c3 103,500       Basic Science
(31) Marine Biological Laboratory
7 MBL Street
Woods Hole,MA02543 		04-2104690 501 c3 103,330       Basic Science
(32) Mayo Clinic Rochester
200 First Street Southwest
Rochester,MN55906 		41-6011702 501 c3 103,500       Basic Science
(33) Medical College of Wisconsin
8701 Watertown Plank Rd
Milwaukee,WI53226 		39-0806261 501 c3 207,000       Basic Science
(34) Mount Sinai School of Medicine
One Gustav L Levy Place Box 3500
New York,NY10029 		13-6171197 501 c3 413,811       Basic Science
(35) Northwestern University
633 Clark Street Room 2-502
Evanston,IL60208 		36-2167817 501 c3 103,500       Basic Science
(36) Oregon Health & Science University
3181 SW Sam Jackson Park Rd L106 Ro
Portland,OR97239 		93-1176109 501 c3 103,500       Basic Science
(37) Pennington Biomedical Research Center
6400 Perkins Road
Baton Rouge,LA70808 		72-6000848 501 c3 103,500       Basic Science
(38) The Regents of the University of California Davis
One Shields Avenue
Davis,CA95616 		94-6036494 501 c3 103,500       Basic Science
(39) Regents of the University of Minnesota
450 McNamara Alumni Center
Minneapolis,MN55455 		41-6007513 501 c3 103,500       Basic Science
(40) Research Foundation of the State University of New York - Albany
PO Box 9
Albany,NY12201 		14-1368361 501 c3 103,500       Basic Science
(41) Sanford-Burnham Medical Research Institute
10901 North Torrey Pines Road
La Jolla,CA92037 		51-0197108 501 c3 207,000       Basic Science
(42) State University of New York Upstate Medical University
750 East Adams Street
Syracuse,NY13210 		16-1450994 501 c3 207,000       Basic Science
(43) Temple University School of Medicine
PO Box 824242
Philadelphia,PA19182 		23-1365971 501 c3 207,000       Basic Science
(44) The Board of Regents of the University of Wisconsin System
21 N Park Street Suite 6401
Madison,WI53715 		39-6006492 501 c3 103,500       Basic Science
(45) The Methodist Hospital Research Institute
6565 Fannin St GB 240
Houston,TX77030 		87-0721923 501 c3 103,492       Basic Science
(46) Ohio State University Medical Center
POBox 21781
Columbus,OH43221 		31-1166607 501 c3 103,500       Basic Science
(47) The Rector and Visitors of the University of Virginia
914 Emmet St N
Charlottesville,VA22903 		54-6001796 501 c3 103,500       Basic Science
(48) The Regents of the University of California Davis
One Shields Avenue
Davis,CA95616 		94-6036494 501 c3 207,000       Basic Science
(49) The Regents of the University of California San Diego
9500 Gilman Drive 0954
La Jolla,CA92093 		95-6006144 501 c3 103,500       Basic Science
(50) Tulane University
6823 St Charles Avenue
New Orleans,LA70118 		72-0423889 501 c3 207,000       Basic Science
(51) University of Alabama at Birmingham
1530 3rd Ave South AB 990
Birmingham,AL35294 		63-6005396 501 c3 310,500       Basic Science
(52) The University of Chicago
1225 E 60th Street
Chicago,IL60637 		36-2177139 501 c3 103,500       Basic Science
(53) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 310,500       Basic Science
(54) University of Illinois at Chicago
809 S Marshfield Ave
Chicago,IL60612 		37-6000511 501 c3 207,000       Basic Science
(55) University of Iowa
4 Jessup Hall Room B5
Iowa City,IA52242 		42-6004813 115 97,821       Basic Science
(56) University of Louisville Research Foundation Inc
Office of Controller Service Comple
Louisville,KY40292 		23-7078461 501 c3 103,500       Basic Science
(57) University of Maryland School of Medicine
620 W Lexington Street
Baltimore,MD21201 		52-6002033 115 207,000       Basic Science
(58) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 621,000       Basic Science
(59) Regents of the University of Minnesota
450 McNamara Alumni Center
Minneapolis,MN55455 		41-6007513 501 c3 103,414       Basic Science
(60) University of Mississippi Medical Center
2500 North State St Office of Devel
Jackson,MS39216 		64-6008520 501 c3 19,768       Basic Science
(61) University of Nevada School of Medicine
401 W 2nd St
Reno,NV89503 		88-0387136 501 c3 103,500       Basic Science
(62) University of Pennsylvania
3451 Walnut St P-221 Frankin Buildi
Philadelphia,PA19104 		23-1352685 501 c3 411,110       Basic Science
(63) University of Pittsburgh
116 Atwood Street Suite 201
Pittsburg,PA15260 		25-0965591 501 c3 290,193       Basic Science
(64) University of Rochester Medical Center
910 Genesee Street Brooks Landing B
Rochester,NY14611 		16-0743209 501 c3 103,500       Basic Science
(65) University of Southern California
1540 Alcazar Street CHP 100
Los Angeles,CA90033 		95-1642394 501 c3 207,000       Basic Science
(66) University of Texas at El Paso
500 West University Avenue
El Paso,TX79968 		74-6000813 170c1 103,500       Basic Science
(67) University of Texas Health Science Center at Houston
7000 Fannin St
Houston,TX77030 		74-1586031 170c1 103,500       Basic Science
(68) University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio,TX78229 		74-1586031 170c1 310,500       Basic Science
(69) University of Texas Medical Branch
301 University Boulevard
Galveston,TX77555 		74-6000949 170c1 103,500       Basic Science
(70) University of Texas Southwestern Medical Center at Dallas
PO Box 841753
Dallas,TX75284 		75-6002868 170c1 236,979       Basic Science
(71) University of Toledo Health Science Campus
2801 W Bancroft Street MS 451
Toledo,OH43606 		34-6401483 501 c3 103,472       Basic Science
(72) University of Utah
201 South Presidents Circle Rm 406
Salt Lake City,UT84112 		87-6000525 501 c3 207,000       Basic Science
(73) University of Virginia
PO Box 400195
Charlottesville,VA22904 		54-6001796 501 c3 199,283       Basic Science
(74) USDA ARS Western Human Nutrition Research Center
430 West Health Sciences Drive
Davis,CA95616 		72-0564834 115 99,900       Basic Science
(75) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 207,000       Basic Science
(76) Washington University in St Louis
700 Rose Dale Ave Box 1034
St Louis,MO63112 		43-0653611 501 c3 103,500       Basic Science
(77) Wayne State University School of Medicine
5057 Woodward Avenue 13th floor Sui
Detroit,MI48202 		38-6028429 501 c3 207,000       Basic Science
(78) West Virginia University Research Corporation
886 Chestnut Ridge Road No 408
Morgantown,WV26506 		55-0665758 501 c3 103,500       Basic Science
(79) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 414,000       Basic Science
(80) Albany Medical College
47 New Scotland Avenue Mc-116
Albany,NY12208 		14-1338310 501 c3 103,500       Basic Science
(81) Baylor College of Medicine
One Baylor Plaza
Houston,TX77030 		74-1613878 501 c3 310,500       Basic Science
(82) Boston University School of Medicine
715 Albany Street M-921
Boston,MA02118 		04-2103547 501 c3 147,160       Basic Science
(83) Beckman Research Institute of the City of Hope
1450 East Duarte Road
Duarte,CA91010 		95-3432210 501 c3 103,500       Basic Science
(84) Colorado State University
408 University Services Center
Fort Collins,CO80523 		84-6000545 115 103,492       Basic Science
(85) Columbia University
POBox 29789
New York,NY10987 		13-5598093 501 c3 103,500       Basic Science
(86) Georgia Health Sciences University
1120 15th Street
Augusta,GA30912 		58-1418202 501 c3 5,046       Basic Science
(87) Saint Louis University
3545 Lindell Boulevard
Saint Louis,MO63103 		43-0654872 501 c3 207,000       Basic Science
(88) State University of New York at Buffalo
12 Capen Hall
Buffalo,NY14260 		16-1514621 501 c3 103,500       Basic Science
(89) The Cleveland Clinic Foundation
9500 Euclid Avenue NO H-18
Cleveland,OH44195 		91-2153073 501 c3 103,500       Basic Science
(90) The Jackson Laboratory
600 Main Street POBox 9741
Bar Harbor,ME04609 		01-0211513 501 c3 103,500       Basic Science
(91) Thomas Jefferson University
201 South 11th Street Martin Buildi
Philadelphia,PA19107 		23-1352651 501 c3 103,500       Basic Science
(92) State University of New York at Buffalo
12 Capen Hall
Buffalo,NY14260 		16-1514621 501 c3 103,500       Basic Science
(93) University of Cincinnati
PO Box 210061
Cincinnati,OH45221 		31-6000989 501 c3 103,500       Basic Science
(94) University of Louisville
Office of Controller Service Comple
Louisville,KY40292 		61-1029626 501 c3 413,998       Basic Science
(95) University of Massachusetts Medical School
55 Lake Avenue North
Worcester,MA01655 		04-3167352 115 101,147       Basic Science
(96) University of Tennessee Health Science Center
62 Dunlap Suite 300
Memphis,TN38163 		62-6001636 501 c3 103,500       Basic Science
(97) University of Washington
Gerberding Hall G80 Box 351202
Seattle,WA98195 		91-6001537 115 103,500       Basic Science
(98) Virginia Polytechnic Institute and State University
1880 Pratt Drive Suite 2006
Blacksburg,VA24060 		54-6001805 501 c3 103,185       Basic Science
(99) Los Angeles Biomedical Research Institute
1124 West Carson Street Bldg N-16
Torrance,CA90502 		95-2138184 501 c3 60,000       Basic Science - Bridge Funding Award
(100) Texas A&M AgriLife Research
2147 Tamu
College Station,TX77843 		74-6000541 501 c3 60,000       Basic Science - Bridge Funding Award
(101) The Cleveland Clinic Foundation
9500 Euclid Avenue NO H-18
Cleveland,OH44195 		91-2153073 501 c3 60,000       Basic Science - Bridge Funding Award
(102) University of Kansas Medical Center
3901 Rainbow Blvd
Kansas City,KS66160 		23-7414917 501 c3 60,000       Basic Science - Bridge Funding Award
(103) University of Massachusetts Medical School
55 Lake Avenue North
Worcester,MA01655 		04-3167352 115 60,000       Basic Science - Bridge Funding Award
(104) University of South Alabama Medical Center
2451 Fillingim Street
Mobile,AL36617 		63-6057293 501 c3 60,000       Basic Science - Bridge Funding Award
(105) University of Tennessee Health Science Center
62 Dunlap Suite 300
Memphis,TN38163 		62-6001636 501 c3 60,000       Basic Science - Bridge Funding Award
(106) University of Wyoming
2011 Fairgrounds Road
Casper,WY82604 		51-0168411 501 c3 60,000       Basic Science - Bridge Funding Award
(107) Children's Hospital Boston
PO Box 41444
Boston,MA02115 		04-2774441 501 c3 155,250       Career Development
(108) Weill Medical College of Cornell University
100 Broadway 8th Floor
New York,NY10005 		13-1623978 501 c3 177,750       Career Development
(109) Mayo Clinic Jacksonville
4500 San Pablo Road
Jacksonville,FL32224 		59-3337028 501 c3 155,250       Career Development
(110) Mount Sinai School of Medicine
One Gustav L Levy Place Box 3500
New York,NY10029 		13-6171197 501 c3 177,750       Career Development
(111) New York Institute of Technology College of Osteopathic Medicine (NYIT-COM)
Northern Blvd PO Box 8000
Old Westbury,NY11568 		11-1788788 501 c3 155,240       Career Development
(112) Oregon Health & Science University
3181 SW Sam Jackson Park Rd L106 Ro
Portland,OR97239 		93-1176109 501 c3 154,719       Career Development
(113) University of Alabama at Birmingham
1530 3rd Ave South AB 990
Birmingham,AL35294 		63-6005396 501 c3 177,750       Career Development
(114) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 485,313       Career Development
(115) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 155,250       Career Development
(116) University of Kentucky Research Foundation
109 Kinkead Hall
Lexington,KY40506 		61-6033693 501 c3 155,250       Career Development
(117) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 177,750       Career Development
(118) Albert Einstein College of Medicine
1300 Morris Park Ave
Bronx,NY10461 		13-1624225 501 c3 180,000       Clinical Science and Epidemiology
(119) Joslin Diabetes Center
One Joslin Place
Boston,MA02215 		04-2203836 501 c3 180,000       Clinical Science and Epidemiology
(120) Research Institute at Nationwide Children's Hospital
700 Childerns DR
Columbus,OH43205 		01-0782751 501 c3 90,000       Clinical Science and Epidemiology
(121) The University of Arizona
888 N Euclid Ave Room 510 PO Box 33
Tucson,AZ85719 		74-2652689 115 179,966       Clinical Science and Epidemiology
(122) University of South Florida
4202 East Fowler Avenue ALC 100
Tampa,FL33620 		23-7357236 501 c3 180,000       Clinical Science and Epidemiology
(123) University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio,TX78229 		74-1586031 170c1 180,000       Clinical Science and Epidemiology
(124) Virginia Polytechnic Institute and State University
1880 Pratt Drive Suite 2006
Blacksburg,VA24060 		54-6001805 501 c3 179,999       Clinical Science and Epidemiology
(125) Washington University in St Louis
700 Rose Dale Ave Box 1034
St Louis,MO63112 		43-0653611 501 c3 360,000       Clinical Science and Epidemiology
(126) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 100,000       Clinical Science and Epidemiology - Bridge Funding Award
(127) Ohio State University Medical Center
POBox 21781
Columbus,OH43221 		31-1166607 501 c3 27,000       Clinical Scientist Training
(128) University of Illinois at Chicago
809 S Marshfield Ave
Chicago,IL60612 		37-6000511 501 c3 27,000       Clinical Scientist Training
(129) Albert Einstein College of Medicine
1300 Morris Park Ave
Bronx,NY10461 		13-1624225 501 c3 360,000       Clinical/Translational Research
(130) Arizona State University
PO Box 873503
Tempe,AZ85287 		86-0196696 115 178,963       Clinical/Translational Research
(131) Emory University School of Medicine
1599 Clifton Road NE 4th Floor MAIL
Atlanta,GA30322 		58-0566256 501 c3 180,000       Clinical/Translational Research
(132) Joslin Diabetes Center
One Joslin Place
Boston,MA02215 		04-2203836 501 c3 360,000       Clinical/Translational Research
(133) Los Angeles Biomedical Research Institute
1124 West Carson Street Bldg N-16
Torrance,CA90502 		95-2138184 501 c3 179,849       Clinical/Translational Research
(134) Massachusetts Eye and Ear Infirmary
23 Charles Street
Boston,MA02114 		04-2103591 501 c3 177,768       Clinical/Translational Research
(135) Massachusetts General Hospital
50 Staniford Street 10th Floor
Boston,MA02214 		04-2697983 501 c3 180,000       Clinical/Translational Research
(136) Ohio State University Medical Center
POBox 21781
Columbus,OH43221 		31-1166607 501 c3 180,000       Clinical/Translational Research
(137) Old Dominion University
5115 Hampton Boulevard
Norfolk,VA23529 		54-6052014 501 c3 179,999       Clinical/Translational Research
(138) Palo Alto Medical Foundation
2350 El Camino Real
Mountain View,CA94040 		94-1156581 501 c3 89,508       Clinical/Translational Research
(139) Diabetes Research Center University of California- San Diego
9500 Gilman Drive 0954
La Jolla,CA92093 		95-6006144 501 c3 180,000       Clinical/Translational Research
(140) Stanford University School of Medicine
300 Pasteur Drive
Stanford,CA94305 		94-1156365 501 c3 169,408       Clinical/Translational Research
(141) State University of New York at Buffalo
12 Capen Hall
Buffalo,NY14260 		16-1514621 501 c3 179,975       Clinical/Translational Research
(142) Texas A&M University System Health Science Center
400 Harvey Mitchell Parkway South
College Station,TX77845 		74-1238434 501 c3 88,232       Clinical/Translational Research
(143) The Cleveland Clinic Foundation
9500 Euclid Avenue NO H-18
Cleveland,OH44195 		91-2153073 501 c3 67,529       Clinical/Translational Research
(144) University of Alabama at Birmingham
1530 3rd Ave South AB 990
Birmingham,AL35294 		63-6005396 501 c3 103,397       Clinical/Translational Research Clinical/Translational Research Clinical/Translational Research Clinical/Translational Research Clinical/Translational Research Clinical/Translational Research Clinical/Translational Research
(145) The University of Chicago
1225 E 60th Street
Chicago,IL60637 		36-2177139 501 c3 180,000       Clinical/Translational Research
(146) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 180,000       Clinical/Translational Research
(147) University of Maryland School of Medicine
620 W Lexington Street
Baltimore,MD21201 		52-6002033 115 180,000       Clinical/Translational Research
(148) Regents of the University of Minnesota
450 McNamara Alumni Center
Minneapolis,MN55455 		41-6007513 501 c3 360,000       Clinical/Translational Research
(149) University of Pittsburgh
116 Atwood Street Suite 201
Pittsburg,PA15260 		25-0965591 501 c3 179,867       Clinical/Translational Research
(150) University of South Carolina Research Foundation
915 Bull St Osborne Administration
Columbia,SC29208 		51-0517254 501 c3 71,590       Clinical/Translational Research
(151) University of Tennessee Health Science Center
62 Dunlap Suite 300
Memphis,TN38163 		62-6001636 501 c3 180,000       Clinical/Translational Research
(152) University of Virginia
PO Box 400195
Charlottesville,VA22904 		54-6001796 501 c3 180,000       Clinical/Translational Research
(153) Washington University in St Louis
700 Rose Dale Ave Box 1034
St Louis,MO63112 		43-0653611 501 c3 539,929       Clinical/Translational Research
(154) Tufts Medical Center
800 Washington Street BOX 468
Boston,MA02111 		27-0440772 501 c3 300,000       Vitamin D and Type 2 Diabetes Co-Support Award
(155) Boston University School of Medicine
715 Albany Street M-921
Boston,MA02118 		04-2103547 501 c3 44,462       Innovation
(156) Brigham and Women's Hospital
75 Francis Street
Boston,MA02115 		04-2312909 501 c3 45,000       Innovation
(157) Case Western Reserve University
10900 Euclid Avenue
Cleveland,OH44106 		34-1018992 501 c3 45,000       Innovation
(158) Cedars-Sinai Medical Center
8700 Beverly Blvd
W Hollywood,CA90048 		95-1644600 501 c3 45,000       Innovation
(159) Children's Hospital Boston
PO Box 41444
Boston,MA02115 		04-2774441 501 c3 45,000       Innovation
(160) Florida State University
282 Champions Way A2201 Uca
Tallahassee,FL32306 		59-1961248 501 c3 45,000       Innovation
(161) Georgetown University
37th and O Street NW
Washington,DC20057 		53-0196603 501 c3 44,496       Innovation
(162) Harvard University
1033 Massachusetts Ave Ste 3
Cambridge,MA02138 		04-2103580 501 c3 45,000       Innovation
(163) Indiana University School of Medicine
PO Box 66057
Indianapolis,IN46266 		35-6001673 501 c3 43,172       Innovation
(164) Medical University of South Carolina
18 Bee Street
Charleston,SC29425 		57-6028985 501 c3 90,000       Innovation
(165) Trustees of Purdue University
401 S Grant Street
West Lafayette,IN47907 		35-6002041 501 c3 45,000       Innovation
(166) Schepens Eye Research Institute Harvard Medical School
20 Staniford Street
Boston,MA02114 		04-2129889 501 c3 45,000       Innovation
(167) University of Alabama at Birmingham
1530 3rd Ave South AB 990
Birmingham,AL35294 		63-6005396 501 c3 45,000       Innovation
(168) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 40,375       Innovation
(169) University of Iowa
4 Jessup Hall Room B5
Iowa City,IA52242 		42-6004813 115 45,000       Innovation
(170) University of Kentucky Research Foundation
109 Kinkead Hall
Lexington,KY40506 		61-6033693 501 c3 45,000       Innovation
(171) University of Maryland School of Medicine
620 W Lexington Street
Baltimore,MD21201 		52-6002033 115 44,978       Innovation
(172) University of Miami School of Medicine
PO Box 248106
Coral Gables,FL33124 		59-0624458 501 c3 45,000       Innovation
(173) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 45,000       Innovation
(174) University of Oklahoma Health Sciences Center
PO Box 26901 SCB228
Oklahoma City,OK73190 		73-6017987 501 c3 45,000       Innovation
(175) University of Pittsburgh
116 Atwood Street Suite 201
Pittsburg,PA15260 		25-0965591 501 c3 89,716       Innovation
(176) University of Texas Southwestern Medical Center at Dallas
PO Box 841753
Dallas,TX75284 		75-6002868 170c1 44,999       Innovation
(177) University of Washington
Gerberding Hall G80 Box 351202
Seattle,WA98195 		91-6001537 115 45,000       Innovation
(178) University of Wisconsin-Madison
21 N Park Street Suite 6401
Madison,WI53715 		39-6006492 501 c3 45,000       Innovation
(179) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 45,000       Innovation
(180) Johns Hopkins University
1101 E 33RD St Ste D200
Baltimore,MD21218 		52-0595110 501 c3 50,000       Innovation - Bridge Funding Award
(181) Northwestern University
633 Clark Street Room 2-502
Evanston,IL60208 		36-2167817 501 c3 50,000       Innovation - Bridge Funding Award
(182) Ohio State University Medical Center
POBox 21781
Columbus,OH43221 		31-1166607 501 c3 50,000       Innovation - Bridge Funding Award
(183) Children's Hospital Boston
PO Box 41444
Boston,MA02115 		04-2774441 501 c3 124,200       Junior Faculty
(184) Harvard University
1033 Massachusetts Ave Ste 3
Cambridge,MA02138 		04-2103580 501 c3 124,200       Junior Faculty
(185) University of Oklahoma Health Sciences Center
PO Box 26901 SCB228
Oklahoma City,OK73190 		73-6017987 501 c3 247,371       Junior Faculty
(186) Washington University in St Louis
700 Rose Dale Ave Box 1034
St Louis,MO63112 		43-0653611 501 c3 248,400       Junior Faculty
(187) Weill Medical College of Cornell University
100 Broadway 8th Floor
New York,NY10005 		13-1623978 501 c3 124,200       Junior Faculty
(188) Adventist Health System-Sunbelt Inc dba Florida Hospital
900 Hope Way
Altamonte Springs,FL32714 		59-1479658 501 c3 124,200       Junior Faculty
(189) Albert Einstein College of Medicine
1300 Morris Park Ave
Bronx,NY10461 		13-1624225 501 c3 124,200       Junior Faculty
(190) Baylor College of Medicine
One Baylor Plaza
Houston,TX77030 		74-1613878 501 c3 124,200       Junior Faculty
(191) Beth Israel Deaconess Medical Center
330 Brookline Ave E BR-259
Boston,MA02219 		04-2103881 501 c3 123,525       Junior Faculty
(192) Brigham and Women's Hospital
75 Francis Street
Boston,MA02115 		04-2312909 501 c3 247,958       Junior Faculty
(193) Weill Medical College of Cornell University
100 Broadway 8th Floor
New York,NY10005 		13-1623978 501 c3 124,200       Junior Faculty
(194) Eastern Virginia Medical School
PO Box 1980
Norfolk,VA23501 		54-6055378 501 c3 124,200       Junior Faculty
(195) Indiana University School of Medicine
PO Box 66057
Indianapolis,IN46266 		35-6001673 501 c3 124,200       Junior Faculty
(196) Thomas Jefferson University
201 South 11th Street Martin Buildi
Philadelphia,PA19107 		23-1352651 501 c3 248,400       Junior Faculty
(197) Torrey Pines Institute for Molecular Studies
11350 SW Village Parkway
Port St Lucie,FL34987 		33-0319501 501 c3 124,200       Junior Faculty
(198) University of Cincinnati
PO Box 210061
Cincinnati,OH45221 		31-6000989 501 c3 124,200       Junior Faculty
(199) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 243,657       Junior Faculty
(200) University of Iowa
4 Jessup Hall Room B5
Iowa City,IA52242 		42-6004813 115 248,400       Junior Faculty
(201) University of Kansas Medical Center
3901 Rainbow Blvd
Kansas City,KS66160 		23-7414917 501 c3 124,200       Junior Faculty
(202) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 248,303       Junior Faculty
(203) University of Pennsylvania
3451 Walnut St P-221 Frankin Buildi
Philadelphia,PA19104 		23-1352685 501 c3 124,200       Junior Faculty
(204) University of South Carolina Research Foundation
915 Bull St Osborne Administration
Columbia,SC29208 		51-0517254 501 c3 123,974       Junior Faculty
(205) University of Texas Southwestern Medical Center at Dallas
PO Box 841753
Dallas,TX75284 		75-6002868 170c1 124,200       Junior Faculty
(206) University of Virginia
PO Box 400195
Charlottesville,VA22904 		54-6001796 501 c3 248,400       Junior Faculty
(207) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 124,200       Junior Faculty
(208) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 124,200       Junior Faculty
(209) Rutgers The State University of New Jersey
129 Morris Tpke
Newton,NJ07860 		23-7318742 501 c3 70,000       Junior Faculty - Bridge Funding Award
(210) Syracuse University
900 S Crouse Ave Skytop Office Bldg
Syracuse,NY13210 		15-0532081 501 c3 70,000       Junior Faculty - Bridge Funding Award
(211) Brigham and Women's Hospital
75 Francis Street
Boston,MA02115 		04-2312909 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(212) Broad Institute Inc
7 Cambridge Ctr
Cambridge,MA02142 		26-3428781 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(213) Children's Hospital Boston
PO Box 41444
Boston,MA02115 		04-2774441 501 c3 81,000       Mentor-Based Postdoctoral Fellowship
(214) Dana-Farber Cancer Institute
450 Brookline Ave
Boston,MA02215 		04-2263040 501 c3 121,500       Mentor-Based Postdoctoral Fellowship
(215) Harvard University
1033 Massachusetts Ave Ste 3
Cambridge,MA02138 		04-2103580 501 c3 121,500       Mentor-Based Postdoctoral Fellowship
(216) Joslin Diabetes Center
One Joslin Place
Boston,MA02215 		04-2203836 501 c3 162,000       Mentor-Based Postdoctoral Fellowship
(217) La Jolla Institute for Allergy and Immunology
9420 Athena Circle
La Jolla,CA92037 		33-0328688 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(218) Mayo Clinic Rochester
200 First Street Southwest
Rochester,MN55906 		41-6011702 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(219) Salk Institute for Biological Studies
10010 N Torrey Pines Road
San Diego,CA92037 		95-2160097 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(220) Stanford University School of Medicine
300 Pasteur Drive
Stanford,CA94305 		94-1156365 501 c3 81,000       Mentor-Based Postdoctoral Fellowship
(221) The J David Gladstone Institutes
1650 Owens St
San Francisco,CA94158 		23-7203666 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(222) The Regents of the University of California San Francisco
3333 California Street Ste 315
San Francisco,CA94143 		94-6036493 501 c3 121,500       Mentor-Based Postdoctoral Fellowship
(223) University of Florida
302 Tigert Hall PO Box 113001
Gainesville,FL32610 		59-6002052 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(224) University of Maryland School of Medicine
620 W Lexington Street
Baltimore,MD21201 		52-6002033 115 40,500       Mentor-Based Postdoctoral Fellowship
(225) University of Massachusetts Medical School
55 Lake Avenue North
Worcester,MA01655 		04-3167352 115 40,500       Mentor-Based Postdoctoral Fellowship
(226) University of Pennsylvania
3451 Walnut St P-221 Frankin Buildi
Philadelphia,PA19104 		23-1352685 501 c3 25,034       Mentor-Based Postdoctoral Fellowship
(227) University of Texas Southwestern Medical Center at Dallas
PO Box 841753
Dallas,TX75284 		75-6002868 170c1 160,283       Mentor-Based Postdoctoral Fellowship
(228) Weill Medical College of Cornell University
100 Broadway 8th Floor
New York,NY10005 		13-1623978 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(229) Yale University School of Medicine
155 Whitney Avenue Room 230 PO Box
New Haven,CT06510 		06-0646973 501 c3 162,000       Mentor-Based Postdoctoral Fellowship
(230) Beth Israel Deaconess Medical Center
330 Brookline Ave E BR-259
Boston,MA02219 		04-2103881 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(231) Boston Medical Center
One Boston Medical Center Place
Boston,MA02118 		04-3314093 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(232) Columbia University
POBox 29789
New York,NY10987 		13-5598093 501 c3 162,000       Mentor-Based Postdoctoral Fellowship
(233) Massachusetts General Hospital
50 Staniford Street 10th Floor
Boston,MA02214 		04-2697983 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(234) Pacific Northwest Research Institute
720 Broadway
Seattle,WA98122 		91-0667886 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(235) Seattle Institute for Biomedical and Clinical Research
1660 South Columbian Way No S-151F
Seattle,WA98108 		91-1452438 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(236) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 81,000       Mentor-Based Postdoctoral Fellowship
(237) University of Utah
201 South Presidents Circle Rm 406
Salt Lake City,UT84112 		87-6000525 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(238) University of Washington
Gerberding Hall G80 Box 351202
Seattle,WA98195 		91-6001537 115 40,500       Mentor-Based Postdoctoral Fellowship
(239) University of Wisconsin-Madison
21 N Park Street Suite 6401
Madison,WI53715 		39-6006492 501 c3 39,701       Mentor-Based Postdoctoral Fellowship
(240) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(241) Whitehead Institute for Biomedical Research
Nine Cambridge Center
Cambridge,MA02142 		06-1043412 501 c3 40,500       Mentor-Based Postdoctoral Fellowship
(242) Brigham and Women's Hospital
75 Francis Street
Boston,MA02115 		04-2312909 501 c3 40,500       Mentor-Based Postdoctoral Minority Fellowship
(243) Indiana University School of Medicine
PO Box 66057
Indianapolis,IN46266 		35-6001673 501 c3 40,500       Mentor-Based Postdoctoral Minority Fellowship
(244) Oregon Health & Science University
3181 SW Sam Jackson Park Rd L106 Ro
Portland,OR97239 		93-1176109 501 c3 40,500       Mentor-Based Postdoctoral Minority Fellowship Mentor-Based Postdoctoral Minority Fellowship
(245) Pennington Biomedical Research Center
6400 Perkins Road
Baton Rouge,LA70808 		72-6000848 501 c3 40,500       Mentor-Based Postdoctoral Minority Fellowship
(246) University of Michigan
3003 S State St Rm 1054
Ann Arbor,MI48109 		38-6006309 501 c3 38,380       Mentor-Based Postdoctoral Minority Fellowship
(247) University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio,TX78229 		74-1586031 170c1 40,500       Mentor-Based Postdoctoral Minority Fellowship
(248) Vanderbilt University Medical Center
3319 West End Avenue Ste 800
Crystal Ter Nashville,TN37203 		62-0476822 501 c3 6,750       Mentor-Based Postdoctoral Minority Fellowship
(249) Brown University School of Medicine-The Miriam Hospital
10 Prospect St Box G-M155
Providence,RI02912 		05-0258809 501 c3 325,000       Pathway - Investigator New to Diabetes Research Award
(250) National Human Genome Research Institute
31 Center Drive MSC 2152 Building 3
Bethesda,MD20892 		52-0858115 170 c1 82,336       Pathway - Research Career Initiator
(251) Pennsylvania State University
Office of the Controller MC-G230 PO
Hershey,PA17033 		24-6000376 501 c3 100,000       Pathway - Research Career Initiator
(252) University of Southern California
1540 Alcazar Street CHP 100
Los Angeles,CA90033 		95-1642394 501 c3 325,000       Pathway - Early Investigator Award
(253) University of Washington
Gerberding Hall G80 Box 351202
Seattle,WA98195 		91-6001537 115 325,000       Pathway - Early Investigator Award
(254) Seattle Institute for Biomedical and Clinical Research
1660 South Columbian Way No S-151F
Seattle,WA98108 		91-1452438 501 c3 85,000       RISE Federal Co-Support Award
(255) Regents of the University of Minnesota
450 McNamara Alumni Center
Minneapolis,MN55455 		41-6007513 501 c3 100,000       Translational Science Award - Bridge Funding
(256) Baylor College of Medicine
One Baylor Plaza
Houston,TX77030 		74-1613878 501 c3 180,000       Translational Science Award
(257) University of Colorado Denver
PO Box 238
Denver,CO80291 		84-6000555 501 c3 179,950       Translational Science Award
(258) School of Allied Health University of Connecticut
263 Farmington Ave
Farmington,CT06030 		06-0772160 501 c1 180,000       Translational Science Award
(259) University of Pittsburgh
116 Atwood Street Suite 201
Pittsburg,PA15260 		25-0965591 501 c3 180,000       Translational Science Award
(260) University of Texas Southwestern Medical Center at Dallas
PO Box 841753
Dallas,TX75284 		75-6002868 170c1 179,128       Translational Science Award
(261) Wayne State University School of Medicine
5057 Woodward Avenue 13th floor Sui
Detroit,MI48202 		38-6028429 501 c3 180,000       Translational Science Award
2
Enter total number of section 501(c)(3) and government organizations listed in the line 1 table ................ Bullet Image
130
3
Enter total number of other organizations listed in the line 1 table ........................ . Bullet Image
1
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50055P
Schedule I (Form 990) 2013

Schedule I (Form 990) 2013
Page 2
Part III
Grants and Other Assistance to Individuals in the United States. Complete if the organization answered "Yes" to Form 990, Part IV, line 22.
Part III can be duplicated if additional space is needed.
(a)Type of grant or assistance (b)Number of
recipients		 (c)Amount of
cash grant		 (d)Amount of
non-cash assistance		 (e)Method of valuation (book,
FMV, appraisal, other)		 (f)Description of non-cash assistance
(1) Junior Faculty Stipend Award 8 72,000     N/A
(2) Minority Undergraduate Internship 1 3,000     N/A










Part IV
Supplemental Information. Provide the information required in Part I, line 2, Part III, column (b), and any other additional information.
Return Reference Explanation
Part I Line 2 The American Diabetes Association Research Foundation closely monitors the use of grant funds. Each grantee is required to submit an Annual Progress Report, which includes a scientific and a financial portion, 30 days after the end of each previously committed funding year. Each year of funding after the first is contingent upon approval of the Annual Progress Report and the availability of funds. If the complete report is not received within 90 days after the due date, the award will be terminated. After the completion of the final year of the grant, a Cumulative Final Report, which includes a scientific and financial portion, is due within 60 days after the expiration date of the grant. If the complete final report is not received by the due date, the grantee will not be eligible to apply for any future awards until the obligations for the award are complete.
Part III Line 1,2 The American Diabetes Association Research Foundation program provides support to undergraduate minority students and young scientists through Junior Faculty Stipend Awards and Minority Undergraduate Internship. The Foundation Junior Faculty Stipend award is designed to support new faculty level investigators. The award supports an individuals salary and research project through an annual loan repayment. The Minority Undergraduate Internship award funds the training of an underrepresented minority undergraduate student as she/he gains valuable experience in diabetes research through a one year internship.
Schedule I (Form 990) 2013


Additional Data


Software ID: 13000230
Software Version: 13.6.0.0


Schedule J
(Form 990)
Department of the Treasury
Internal Revenue Service
Compensation Information
For certain Officers, Directors, Trustees, Key Employees, and Highest
Compensated Employees
SchJMediumBullet Complete if the organization answered "Yes" to Form 990, Part IV, line 23.
SchJMediumBullet Attach to Form 990. SchJMediumBullet See separate instructions.
SchJMediumBullet Information about Schedule J (Form 990) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
Questions Regarding Compensation
Yes
No
1a
Check the appropiate box(es) if the organization provided any of the following to or for a person listed in Form
990, Part VII, Section A, line 1a. Complete Part III to provide any relevant information regarding these items.
b
If any of the boxes in line 1a are checked, did the organization follow a written policy regarding payment or reimbursement or provision of all of the expenses described above? If "No," complete Part III to explain....
1b
 
 
2
Did the organization require substantiation prior to reimbursing or allowing expenses incurred by all
directors, trustees, officers, including the CEO/Executive Director, regarding the items checked in line 1a? ..
2
 
 
3
Indicate which, if any, of the following the filing organization used to establish the compensation of the
organization's CEO/Executive Director. Check all that apply. Do not check any boxes for methods
used by a related organization to establish compensation of the CEO/Executive Director, but explain in Part III.
4
During the year, did any person listed in Form 990, Part VII, Section A, line 1a with respect to the filing organization or a related organization:
a
Receive a severance payment or change-of-control payment? ................
4a
 
No
b
Participate in, or receive payment from, a supplemental nonqualified retirement plan? .........
4b
Yes
 
c
Participate in, or receive payment from, an equity-based compensation arrangement? .........
4c
 
No
If "Yes" to any of lines 4a-c, list the persons and provide the applicable amounts for each item in Part III.
Only 501(c)(3) and 501(c)(4) organizations only must complete lines 5-9.
5
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the revenues of:
a
The organization? ...........................
5a
 
No
b
Any related organization? .........................
5b
 
No
If "Yes," to line 5a or 5b, describe in Part III.
6
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization pay or accrue any
compensation contingent on the net earnings of:
a
The organization? ...........................
6a
 
No
b
Any related organization? .........................
6b
 
No
If "Yes," to line 6a or 6b, describe in Part III.
7
For persons listed in Form 990, Part VII, Section A, line 1a, did the organization provide any non-fixed
payments not described in lines 5 and 6? If "Yes," describe in Part III ............
7
 
No
8
Were any amounts reported in Form 990, Part VII, paid or accured pursuant to a contract that was
subject to the initial contract exception described in Regulations section 53.4958-4(a)(3)? If "Yes," describe
in Part III .............................
8
 
No
9
If "Yes" to line 8, did the organization also follow the rebuttable presumption procedure described in Regulations section 53.4958-6(c)? .........................
9
 
 
For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50053T
Schedule J (Form 990) 2013

Schedule J (Form 990) 2013
Page 2
Part II
Officers, Directors, Trustees, Key Employees, and Highest Compensated Employees. Use duplicate copies if additional space is needed.
For each individual whose compensation must be reported in Schedule J, report compensation from the organization on row (i) and from related organizations, described in the
instructions, on row (ii). Do not list any individuals that are not listed on Form 990, Part VII.
Note. The sum of columns (B)(i)-(iii) for each listed individual must equal the total amount of Form 990, Part VII, Section A, line 1a, applicable column (D) and (E) amounts for that individual.
(A) Name and Title (B) Breakdown of W-2 and/or 1099-MISC compensation (C) Retirement and other deferred compensation (D) Nontaxable
benefits		 (E) Total of columns
(B)(i)-(D) 		(F) Compensation
reported as deferred
in prior Form 990
(i) Base compensation (ii) Bonus & incentive compensation (iii) Other reportable compensation
(1)Larry HausnerChief Executive Officer (i)
(ii)		  
490,544 		 
77,846 		 
25,266 		 
115,500 		 
25,875 		 
735,031 		 
77,846
(2)Deborah L JohnsonChief Financial Officer (i)
(ii)		  
234,927 		 
  		 
2,331 		 
39,720 		 
18,605 		 
295,583 		 
 
(3)Robert Ratner MD FACP FACEChief Scientific Medical Officer (i)
(ii)		  
406,194 		 
26,680 		 
5,655 		 
45,958 		 
1,603 		 
486,090 		 
 
Schedule J (Form 990) 2013

Schedule J (Form 990) 2013
Page 3
Part III
Supplemental Information
Provide the information, explanation, or descriptions required for Part I, lines 1a, 1b, 3, 4a, 4b, 4c, 5a, 5b, 6a, 6b, 7, and 8, and for Part II.
Also complete this part for any additional information.
Return Reference Explanation
Part I Line 3 The Chief Executive Officer, the Chief Financial Officer, and Chief Scientific Medical Officer of the American Diabetes Association the Association also serve in these roles for the American Diabetes Association Research Foundation the Foundation. The Principal Officers of the Board of Directors of the Association use a Compensation Committee, compensation studies, and an independent consultant to establish the compensation of the Chief Executive Officer. The committee also reviews the compensation of the other officers to ensure compensation is appropriate based on industry benchmarks.
Part I Line 4b The Chief Executive Officer is compensated by the American Diabetes Association and participates in its supplemental retirement plan. The reported retirement and other deferred compensation includes contributions to the Chief Executive Officers 457f plan in the amounts of 90,544 for an annual contribution.
Schedule J (Form 990) 2013

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0
Schedule L
(Form 990 or 990-EZ)
Department of the Treasury
Internal Revenue Service
Transactions with Interested Persons
MediumBullet Complete if the organization answered
"Yes" on Form 990, Part IV, lines 25a, 25b, 26, 27, 28a, 28b, or 28c,
or Form 990-EZ, Part V, line 38a or 40b.
MediumBullet Attach to Form 990 or Form 990-EZ. MediumBullet See separate instructions.
MediumBulletInformation about Schedule L (Form 990 or 990-EZ) and its instructions is at www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
Excess Benefit Transactions (section 501(c)(3) and section 501(c)(4) organizations only).
Complete if the organization answered "Yes" on Form 990, Part IV, line 25a or 25b, or Form 990-EZ, Part V, line 40b.
1(a) Name of disqualified person (b) Relationship between disqualified person and organization (c) Description of transaction (d) Corrected?
Yes No





2
Enter the amount of tax incurred by organization managers or disqualified persons during the year under section 4958. ........................... Bullet Image$
 
3
Enter the amount of tax, if any, on line 2, above, reimbursed by the organization ....... Bullet Image$
 

Part II
Loans to and/or From Interested Persons.
Complete if the organization answered "Yes" on Form 990-EZ, Part V, line 38a, or Form 990, Part IV, line 26; or if the organization reported an amount on Form 990, Part X, line 5, 6, or 22
(a) Name of interested person (b) Relationship with organization (c) Purpose of loan (d) Loan to or from the organization? (e)Original principal amount (f)Balance due (g) In default? (h) Approved by board or committee? (i)Written agreement?
To From Yes No Yes No Yes No
Total ......Small Bullet $  
Part III
Grants or Assistance Benefitting Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 27.
(a) Name of interested person (b) Relationship between interested person and the organization (c) Amount of assistance (d) Type of assistance (e) Purpose of assistance
(1) A Gordon Smith MD - University of U Grant Review Committee Member 199,868   ADA Ethicon Covidien - Clinical
(2) Alex F Chen MD PhD - University of Grant Review Committee Member 103,500   Basic Science
(3) Alyssa H Hasty PhD - Vanderbilt Uni Grant Review Committee Member 6,750   Mentor-Based Minority Postdoctoral Fellowship
(4) Anders H Berg MD PhD - Beth Israel Grant Review Committee Member 123,525   Junior Faculty
(5) Antonello Pileggi MD - University o Grant Review Committee Member 45,000   Innovation
(6) Brian T Layden MD PhD - Northwester Grant Review Committee Member 50,000   Innovation-Bridge Funding
(7) Brian Thomas Fife PhD - Regents of Grant Review Committee Member 100,000   Translational Science - Bridge Funding
(8) Burton M Wice PhD - Washington Univ Grant Review Committee Member 180,000   Clinical Science and Epidemiology
(9) Carey Nien-Kai Lumeng MD PhD - Univ Grant Review Committee Member 177,750   Career Development
(10) Carlos Bernal-Mizrachi MD - Washing Grant Review Committee Member 180,000   Clinical/Translational Research
(11) Christoph Buettner MD PhD - Mount S Grant Review Committee Member 177,750   Career Development
(12) Clayton E Mathews PhD - University Grant Review Committee Member 103,500   Basic Science
(13) David A Bernlohr PhD - University o Grant Review Committee Member 180,000   Clinical/Translational Research
(14) David H Wagner PhD - Regents of the Grant Review Committee Member 179,950   Translational Science
(15) Dennis C Bruemmer MD PhD - Universi Grant Review Committee Member 155,250   Career Development
(16) Donald K Scott PhD - Mount Sinai Sc Grant Review Committee Member 103,500   Basic Science
(17) Dongmin Liu PhD - Virginia Polytech Grant Review Committee Member 103,185   Basic Science
(18) Dongsheng Cai MD PhD - Albert Einst Grant Review Committee Member 103,500   Basic Science
(19) Elizabeth Jane Parks PhD - Universi Grant Review Committee Member 179,128   Translational Science
(20) Fajun Yang PhD - Albert Einstein Co Grant Review Committee Member 103,500   Basic Science
(21) George Gilbert Holz PhD - State Uni Grant Review Committee Member 103,500   Basic Science
(22) Gerald M Reaven MD - Stanford Unive Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(23) Guillermo E Umpierrez MD - Emory Un Grant Review Committee Member 180,000   Clinical/Translational Research
(24) Hubert Ming Tse PhD - University of Grant Review Committee Member 177,750   Career Development
(25) Irene Elizabeth Schauer MD - Univer Grant Review Committee Member 119,457   Junior Faculty
(26) Janet K Snell-Bergeon PhD - Regents Grant Review Committee Member 177,731   Career Development
(27) Jang H Youn PhD - University of Sou Grant Review Committee Member 103,500   Basic Science
(28) Janice Christine Zgibor PhD - Unive Grant Review Committee Member 235,414   ADA-sanofi-aventis U.S. Award in Health Services Research in Clinical Care Delivery in Diabetes
(29) Jeonga Kim PhD - University of Alab Grant Review Committee Member 103,500   Basic Science
(30) Ji Li PhD - State University of New Grant Review Committee Member 103,500   Basic Science
(31) Joanna D Davies PhD - San Diego Dia Grant Review Committee Member 180,000   Clinical/Translational Research
(32) John Peter Mordes MD - University o Grant Review Committee Member 101,147   Basic Science
(33) Jon D Piganelli PhD - University of Grant Review Committee Member 103,500   Basic Science
(34) Jonathan S Bogan MD - Yale Universi Grant Review Committee Member 103,500   Basic Science
(35) Joyce Jezerc Repa PhD - University Grant Review Committee Member 103,500   Basic Science
(36) Judith G Regensteiner PhD - Univers Grant Review Committee Member 180,000   Clinical/Translational Research
(37) Kamal Rahmouni PhD - University of Grant Review Committee Member 103,500   Basic Science
(38) Kenneth Cusi MD - University of Flo Grant Review Committee Member 100,000   Clinical Science and Epidemiology Award - Bridge Funding Award
(39) Kristen Jane Nadeau MD - University Grant Review Committee Member 155,250   Career Development
(40) Kyle Lee Hoehn PhD - University of Grant Review Committee Member 124,200   Junior Faculty
(41) Lu Cai MD PhD - University of Louis Grant Review Committee Member 103,500   Basic Science
(42) Mandeep Bajaj MD - Baylor College o Grant Review Committee Member 180,000   Translational Science
(43) Martin John Hessner PhD - Medical C Grant Review Committee Member 103,500   Basic Science
(44) Matthew W Hulver PhD - Virginia Pol Grant Review Committee Member 179,999   Clinical Science and Epidemiology
(45) Natalie Rasgon MD PhD - Stanford Un Grant Review Committee Member 200,000   ADA-Novo Nordisk Award in Neurohormonal Control of Metabolism
(46) Neil B Ruderman MD - Boston Medical Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(47) Paul R Robertson MD - Pacific North Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(48) Leigh Perreault MD - University of Grant Review Committee Member 152,332   Career Development
(49) Qinglin Yang MD PhD - University of Grant Review Committee Member 103,500   Basic Science
(50) Richard Glenn Kibbey MD PhD - Yale Grant Review Committee Member 103,500   Basic Science
(51) Rosario Scalia MD PhD - Temple Univ Grant Review Committee Member 103,500   Basic Science
(52) Sarah Xin Zhang MD - University of Grant Review Committee Member 103,500   Basic Science
(53) Sean Harrison Adams PhD - USDA ARS Grant Review Committee Member 99,900   Basic Science
(54) Shannon Margaret Wallet PhD - Unive Grant Review Committee Member 155,250   Career Development
(55) Sonia Caprio MD - Yale School of Me Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(56) Steven F Abcouwer PhD - The Regents Grant Review Committee Member 45,000   Innovation
(57) Tamas Laszlo Horvath DVM PhD - Yale Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(58) Timothy E McGraw PhD - Weill Medica Grant Review Committee Member 40,500   Mentor-Based Postdoctoral Fellowship
(59) Todd Michael Brusko PhD - Universit Grant Review Committee Member 103,500   Basic Science
(60) Vijay K Yechoor MD - Baylor College Grant Review Committee Member 103,500   Basic Science
(61) Xin-Liang Ma MD PhD - Thomas Jeffer Grant Review Committee Member 103,500   Basic Science
(62) Young-Bum Kim PhD - Beth Israel Dea Grant Review Committee Member 103,500   Basic Science
(63) Yuchang Fu PhD - The University of Grant Review Committee Member 45,000   Innovation
(64) Yu-Hua Tseng PhD - Joslin Diabetes Grant Review Committee Member 103,500   Basic Science
(65) Zhenqi Liu MD - University of Virgi Grant Review Committee Member 180,000   Clinical/Translational Research
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 50056A
Schedule L (Form 990 or 990-EZ) 2013
Schedule L (Form 990 or 990-EZ) 2013
Page 2
Part IV
Business Transactions Involving Interested Persons.
Complete if the organization answered "Yes" on Form 990, Part IV, line 28a, 28b, or 28c.
(a) Name of interested person (b) Relationship between interested person and the organization (c) Amount of transaction (d) Description of transaction (e) Sharing of organization's revenues?
Yes No
Part V
Supplemental Information
Provide additional information for responses to questions on Schedule L (see instructions).
Return Reference Explanation
Part III Line 1 The Scientific Review Panel follows the requirements of the American Diabetes Association Conflict of Interest Policy when reviewing grant applications and providing funding recommendations. Members must recuse themselves for institutional, financial and personal conflicts of interest. Panel members are not permitted to participate in the grant review process if they are listed as the principal investigator of an application under consideration. In addition, members may not participate in the review of a specific grant if the principal investigator is a close collaborator or close associate of the panel member.
Schedule L (Form 990 or 990-EZ) 2013

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0




SCHEDULE O
(Form 990 or 990-EZ)

Department of the Treasury
Internal Revenue Service
Supplemental Information to Form 990 or 990-EZ

Complete to provide information for responses to specific questions on
Form 990 or to provide any additional information.
MediumBullet Attach to Form 990 or 990-EZ.
MediumBullet Information about Schedule O (Form 990 or 990-EZ) and its instructions is at
www.irs.gov/form990.
OMB No. 1545-0047
2013
Open to Public
Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Return Reference Explanation
Form 990, Part I, Line 1 Organization mission-most significant activities The American Diabetes Association Research Foundation, Inc. the Foundation secures major gifts and grants to fund diabetes-related research leading to the prevention and cure of diabetes, the prevention and cure of the complications of diabetes, and new therapies for individuals affected by diabetes.
Form 990, Part III, Line 4 Research - Taking the Lead in Research The American Diabetes Association direct involvement in diabetes research extends back to the 1940s when Dr. Charles H. Best, one of four scientists credited with discovering insulin, provided the Association with the framework and early leadership for a formalized diabetes research program. Since our Research Program inception in 1952, we have been the leader in funding and supporting cutting-edge diabetes research that has made a crucial difference to people affected by diabetes around the world. In 2013, we made 35.7 million available to support a broad spectrum of diabetes research. Over the years, the Association has supported more than 4,000 research projects and invested more than 675 million in diabetes research. Association-funded research leads to innovative solutions that improve the lives of all people with diabetes. The program supports basic science to increase our understanding of how diabetes develops and identify novel targets for development of new drugs to treat diabetes. Clinical investigations supported by the Association test the effects of new treatments in people with diabetes, and examine the impact of educational and behavioral approaches on diabetes care. Association research has been critical in the development of technologies leading to modern insulin pumps and blood glucose sensors laid the groundwork for development of many of the new classes of oral medications that are now used to prevent and treat diabetes and has provided evidence for the importance of diet and exercise in diabetes management and the role of blood glucose control in reducing complications. New investigators and innovative ideas are critical to improving diabetes care and to finding a cure. Believing in the drive and potential of young and promising researchers, we offer training and career development awards to support scientists interested in diabetes research at the early stages of their research careers -from graduate and medical school through assistant professorship. A focus on early-career researchers and innovation makes the Association research programs distinct from what is funded by the federal government, and is essential to our mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. As evidence of the impact of funding these early career scientists, 98 percent of researchers supported by the Association continue their careers in diabetes research. The primary goals of the Association Research Program are - Support the highest quality science across the broad spectrum of diabetes research.- Support investigators early in their careers to encourage them to dedicate their efforts to diabetes research.- Support innovative research with a high potential to have a significant impact for people with diabetes.
Form 990, Part III, Line 4 Continued... Pathway to Stop Diabetes With the vision of achieving a new generation of brilliant scientists focused on diabetes, the Association officially launched Pathway to Stop Diabetes program in 2013. The Mentor Advisory Group reviewed 115 outstanding applications from research institutions across the U.S. and selected an inaugural class of five Pathway Scientists. This bold initiative will inspire a fresh generation of scientists to discover new diabetes prevention and treatment approaches. Each Pathway award totals of 1.625 million over five to seven years, which allows researchers to have the time and focus needed to explore new ideas. The Association goal is to fund 100 brilliant researchers over the course of the next ten years - a notable assembly of outstanding scientists that will bring unparalleled prestige to the program and attract an ever-increasing elite talent pool from which to identify future candidates. 2013 Research Highlights In 2013, Association-supported researchers made significant progress in understanding how diabetes develops and progresses, and in identifying new ways to potentially combat the disease. Notable discoveries include studies providing new insight into how the brain is impacted by and regulates metabolism, characterizing how brown fat regulates metabolism and can be leveraged to control body weight and metabolism, and testing new ways of manipulating the immune system to slow and potentially reverse autoimmune destruction of beta-cells in type 1 diabetes. Headlines from projects supported by the American Diabetes Association Research Program in 2013 included- Vitamin D Deficiency May Contribute to Clogged Arteries in People with Type 2 Diabetes- Brown Fat Transplant May Aid in Weight Loss and Diabetes Management- Diabetes Risk Increased by Brain Response to Binge Drinking- Detecting diabetes specific CD4T cells in Type 1 Diabetes using tetramer biomarkers- Methane-producing Bacteria in Gut May Increase Risk for Diabetes - Researcher Blocks the Harmful Effects of a High-Fructose Diet- Biological Clock May Influence Obesity and Diabetes- Repairing Nerve Damage in Diabetes- Pathway to Stop Diabetes A Radical New Road for Research- Novel Approach to Suppress Autoimmunity in Type 1 Diabetes- New Open Access Journal Launched in Collaboration with BMJ BMJ is a global academic publisher
Form 990, Part VI, Section A, Line 1a The main responsibilities and focus of the Foundation Board is to advance, support, and promote charitable contributions by soliciting major gifts for the purpose of funding the American Diabetes Association Nationwide Research Program. The Board of Directors of the Foundation provides governance over the activities of the Foundation in accordance with the purposes, policies, and procedures of the American Diabetes Association. The Board delegates to the Foundation Executive Committee responsibility for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundation annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee.
Form 990, Part VI, Section A, Line 3,7a,7b The Foundation affairs are managed by the Foundation Board of Directors. The Board of Directors of the Foundations supervises, directs, and controls the activities of the Foundation in accordance with the mission, purposes, policies and procedures of the American Diabetes Association. The Board delegates to the Foundation Executive Committee responsibility for management of the Foundation when the Board is not in session. The American Diabetes Association provides complete operational support to the Foundation including staff, facilities and administrative processes. The Foundation annual budget and audit process are governed by the American Diabetes Association Board of Directors and Audit Committee. If a vacancy occurs among the Foundation officers for any reason, the Board of Directors of the American Diabetes Association shall fill such position for the unexpired portion of the term.
Form 990, Part VI, Section B, Line 11a IRS Form 990 Review Process by the Governing Body The American Diabetes Association Research Foundation the Foundation draft IRS 990 is reviewed by the American Diabetes Association Audit Committee. The final and signed IRS from 990 was provided to the Association Board of Directors prior to filing with the IRS. The form was made available to the Foundation Board of Directors after filing with the IRS.
Form 990, Part VI, Section B, Line 12c Managing a Conflict of Interest To identify potential conflicts of interest with appropriate due diligence, the Foundations Officers, Directors, and members of the Grant Review Panel must annually disclose any potential conflicts of interest. The American Diabetes Associations Audit Committee and senior staff in legal affairs manage the disclosure and monitoring processes of the Board. The senior staff on the Associations Scientific and Medical Division manage the disclosure and monitoring processes of the Grant Review Panel. Through review of the annual disclosures and review of the agendas of relevant Board, Committee and other meetings, appropriate efforts are made in advance of the meetings to identify potential conflicts of interest. Each person also has the responsibility to report his/her own conflicts of interest actual or perceived as those conflicts may arise during a meeting.
Form 990, Part VI, Section B, Line 12c Research Grants Review Committee Conflict of Interest COI within the Research Grants Review Committee is managed through a written COI policy and through COI declarations signed both before and after the review cycle. The COI for grant reviewers is self-reported. The primary considerations addressed in the COI policy and program guidelines are as follows - Institutional Individuals are required to recuse themselves from reviewing grants for scientists at the same institution, including any institutions with which they may be negotiating employment. - Financial Individuals are required to recuse themselves from reviewing grants from which they stand to gain financially if the grant is awarded co-PI, collaborator, subcontracts, etc.. Personal Individuals are required to recuse themselves from reviewing grants for investigators with whom they either have a personal or professional relationship collaborators, colleagues or personal friends, or a long standing professional or scientific disagreement that prevents them from unbiased review.
Form 990, Part VI, Section B, Line 13 The American Diabetes Association has a written whistleblower policy that applies to the American Diabetes Association Research Foundation.
Form 990, Part VI, Section B, Line 14 The American Diabetes Association has a written Document Retention and Destruction policy that applies to the American Diabetes Association Research Foundation.
Form 990, Part VI, Section C, Line 17 Filing Jurisdiction - Registration Number Alabama - AL97-256, Alaska - N/A, Arkansas - N/A, California - CT81471, Colorado - 2002-3003670, Connecticut - 5084, District of Columbia - 981855, Florida - CH1618, Georgia - CH-001422, Hawaii - N/A, Illinois - CO 01-025537, Indiana - 000103829-000, Kansas - 177-257-3SO, Kentucky - 45, Louisiana - N/A, Maine - CO-1247, Maryland - 102, Massachusetts - O29317, Michigan - MICS 10326, Minnesota - N/A, Mississippi - 100000294, Missouri - CO-021-87, New Hampshire - 5006, New Jersey - CH-0581900, New Mexico - N/A, New York - 01/30/65, North Carolina - SL000618, North Dakota - 7894, Ohio - 01-0239, Oklahoma - N/A, Oregon - 16402, Pennsylvania - No. 21, Rhode Island - 95-233, South Carolina - 641, Tennessee - 5104, Utah - 6536093-Char, Virginia - N/A, Washington - 7664, West Virginia - N/A, Wisconsin -3020-800.
Form 990, Part VI, Section C, Line 19 Document Disclosure The following documents are available on the American Diabetes Association website http//www.diabetes.org Board of Directors, audited Foundation financial statements, IRS Forms 990, and the whistleblower policy. Available subject to request to the American Diabetes Association Legal Affairs department are the following current bylaws, Articles of Incorporation, and the conflict of interest policy.
Form 990, Part VII, Section A, Line 4,7,18 The Chief Executive Officer is a non-voting member of the Research Foundation Board of Directors. The Chief Executive Officer, the Chief Financial Officer, and the Chief Scientific Medical Officer are compensated by the American Diabetes Association based on a standard average of 38 hours per week.
Form 990, Part VII, Line 5,14 Directors referenced were not members of the Board as of December 31, 2013. David Bloomgarden resigned in September 2013, and Ann Juster passed away in June 2013.
Form 990, Part XI, Line 9 Other changes in net assets or fund balances of 625,864 reflect prior year research grant award refunds and forfeitures.
For Paperwork Reduction Act Notice, see the Instructions for Form 990 or 990-EZ.
Cat. No. 51056K
Schedule O (Form 990 or 990-EZ) 2013

Additional Data


Software ID: 13000230
Software Version: 13.6.0.0
SCHEDULE R
(Form 990)
Department of the Treasury
Internal Revenue Service
Related Organizations and Unrelated Partnerships
MediumBulletComplete if the organization answered "Yes" on Form 990, Part IV, line 33, 34, 35b, 36, or 37.
MediumBulletAttach to Form 990. MediumBullet See separate instructions.
MediumBullet Information about Schedule R (Form 990) and its instructions is at www.irs.gov/form990.

OMB No. 1545-0047
2013
Open to Public Inspection
Name of the organization
American Diabetes Association Research Foundation Inc
 
Employer identification number

54-1734511
Part I
Identification of Disregarded Entities Complete if the organization answered "Yes" on Form 990, Part IV, line 33.
(a)
Name, address, and EIN (if applicable) of disregarded entity


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Total income


 		(e)
End-of-year assets


 		(f)
Direct controlling
entity










Part II
Identification of Related Tax-Exempt Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related tax-exempt organizations during the tax year.
(a)
Name, address, and EIN of related organization


(b)
Primary activity


 		(c)
Legal domicile (state
or foreign country)

 		(d)
Exempt Code section


 		(e)
Public charity status
(if section 501(c)(3))

 		(f)
Direct controlling
entity

 		(g)
Section 512(b)(13) controlled entity?
Yes No
(1) American Diabetes Association

1701 N Beauregard Street

Alexandria,VA22311
13-1623888 		See Part VII OH 501 c 3 7 N/A
 
No
(2) American Diabetes Association Property Title Holding Corporation

1701 N Beauregard Street

Alexandria,VA22311
54-1948004 		See Part VII VA 501 c 2 N/A American Diabetes Association
 
Yes
 










For Paperwork Reduction Act Notice, see the Instructions for Form 990.
Cat. No. 50135Y
Schedule R (Form 990) 2013
Schedule R (Form 990) 2013
Page 2
Part III
Identification of Related Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a partnership during the tax year.
(a)
Name, address, and EIN of
related organization



 		(b)
Primary activity




 		(c)
Legal
domicile
(state or foreign
country)


 		(d)
Direct controlling
entity



 		(e)
Predominant income(related, unrelated, excluded from tax under sections 512-514)

(f)
Share of total income




 		(g)
Share of end-of-year
assets



 		(h)
Disproprtionate allocations?




 		(i)
Code V-UBI
amount in box 20 of
Schedule K-1
(Form 1065)
 		(j)
General or
managing
partner?



 		(k)
Percentage
ownership
Yes No Yes No












Part IV
Identification of Related Organizations Taxable as a Corporation or Trust Complete if the organization answered "Yes" on Form 990, Part IV, line 34 because it had one or more related organizations treated as a corporation or trust during the tax year.
(a)
Name, address, and EIN of
related organization
 		(b)
Primary activity
 		(c)
Legal
domicile
(state or foreign
country)
 		(d)
Direct controlling
entity
 		(e)
Type of entity
(C corp, S corp,
or trust) 		(f)
Share of total income
 		(g)
Share of end-of-year
assets
 		(h)
Percentage
ownership
 		(i)
Section 512(b)(13) controlled entity?
Yes No












Schedule R (Form 990) 2013
Schedule R (Form 990) 2013
Page 3
Part V
Transactions With Related Organizations Complete if the organization answered "Yes" on Form 990, Part IV, line 34, 35b, or 36.
Note. Complete line 1 if any entity is listed in Parts II, III, or IV of this schedule.
Yes
No
1 During the tax year, did the orgranization engage in any of the following transactions with one or more related organizations listed in Parts II-IV?
a Receipt of (i) interest (ii) annuities (iii) royalties or (iv) rent from a controlled entity . . . . . . . . . . . . . . . . . . . . . . .
1a
 
No
b Gift, grant, or capital contribution to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1b
 
No
c Gift, grant, or capital contribution from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1c
Yes
 
d Loans or loan guarantees to or for related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1d
 
No
e Loans or loan guarantees by related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1e
 
No
f Dividends from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1f
 
No
g Sale of assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1g
 
No
h Purchase of assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1h
 
No
i Exchange of assets with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1i
 
No
j Lease of facilities, equipment, or other assets to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1j
 
No
k Lease of facilities, equipment, or other assets from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . .
1k
 
No
l Performance of services or membership or fundraising solicitations for related organization(s) . . . . . . . . . . . . . . . . . . . .
1l
 
No
m Performance of services or membership or fundraising solicitations by related organization(s) . . . . . . . . . . . . . . . . . . . .
1m
Yes
 
n Sharing of facilities, equipment, mailing lists, or other assets with related organization(s) . . . . . . . . . . . . . . . . . . . . .
1n
Yes
 
o Sharing of paid employees with related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1o
Yes
 
p Reimbursement paid to related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1p
 
No
q Reimbursement paid by related organization(s) for expenses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1q
 
No
r Other transfer of cash or property to related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1r
 
No
s Other transfer of cash or property from related organization(s) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1s
 
No
2
If the answer to any of the above is "Yes," see the instructions for information on who must complete this line, including covered relationships and transaction thresholds.
(a)
Name of related organization 		(b)
Transaction
type (a-s) 		(c)
Amount involved 		(d)
Method of determining amount involved
(1) American Diabetes Association

 c 37,310,310 Cash
(2) American Diabetes Association

 m,n,o 1,308,995 FMV




Schedule R (Form 990) 2013
Schedule R (Form 990) 2013
Page 4
Part VI
Unrelated Organizations Taxable as a Partnership Complete if the organization answered "Yes" on Form 990, Part IV, line 37.
Provide the following information for each entity taxed as a partnership through which the organization conducted more than five percent of its activities (measured by total assets or gross revenue) that was not a related organization. See instructions regarding exclusion for certain investment partnerships.
(a)
Name, address, and EIN of entity 		(b)
Primary activity 		(c)
Legal domicile
(state or foreign
country) 		(d)
Predominant income (related, unrelated, excluded from tax under sections 512-514)

(e)
Are all partners
section
501(c)(3)
organizations? 		(f)
Share of total income




 		(g)
Share of
end-of-year
assets 		(h)
Disproprtionate allocations? 		(i)
Code V?UBI
amount in box 20
of Schedule K-1
(Form 1065) 		(j)
General or
managing
partner? 		(k)
Percentage
ownership
Yes No Yes No Yes No






























Schedule R (Form 990) 2013
Schedule R (Form 990) 2013
Page 5
Part VII
Supplemental Information
Provide additional information for responses to questions on Schedule R (see instructions).
Return Reference Explanation
Part II Line 1b The mission of the American Diabetes Association is to prevent and cure diabetes and to improve the lives of all people affected by diabetes.
Part II Line 2b The American Diabetes Association Property Title Corporation was established to hold title to real property, collect the income therefrom, and remit to the American Diabetes Association.
Schedule R (Form 990) 2013
Additional Data


Software ID: 13000230
Software Version: 13.6.0.0